0000313616-25-000180.txt : 20251021 0000313616-25-000180.hdr.sgml : 20251021 20251020173947 ACCESSION NUMBER: 0000313616-25-000180 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20251021 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20251021 DATE AS OF CHANGE: 20251020 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DANAHER CORP /DE/ CENTRAL INDEX KEY: 0000313616 STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL INSTRUMENTS FOR MEASUREMENT, DISPLAY, AND CONTROL [3823] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 591995548 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-08089 FILM NUMBER: 251404939 BUSINESS ADDRESS: STREET 1: 2200 PENNSYLVANIA AVE. N.W. STREET 2: SUITE 800W CITY: WASHINGTON STATE: DC ZIP: 20037-1701 BUSINESS PHONE: 2028280850 MAIL ADDRESS: STREET 1: 2200 PENNSYLVANIA AVE. N.W. STREET 2: SUITE 800W CITY: WASHINGTON STATE: DC ZIP: 20037-1701 FORMER COMPANY: FORMER CONFORMED NAME: DMG INC DATE OF NAME CHANGE: 19850221 8-K 1 dhr-20251021.htm 8-K dhr-20251021
false000031361600003136162025-10-212025-10-210000313616us-gaap:CommonStockMember2025-10-212025-10-210000313616dhr:A0.2SeniorNotesDue2026Member2025-10-212025-10-210000313616dhr:A2.1SeniorNotesDue2026Member2025-10-212025-10-210000313616dhr:A1.2SeniorNotesDue2027Member2025-10-212025-10-210000313616dhr:A0.45SeniorNotesDue2028Member2025-10-212025-10-210000313616dhr:A2.5SeniorNotesDue2030Member2025-10-212025-10-210000313616dhr:A0.75SeniorNotesDue2031Member2025-10-212025-10-210000313616dhr:A1.35SeniorNotesDue2039Member2025-10-212025-10-210000313616dhr:A1.8SeniorNotesDue2049Member2025-10-212025-10-21

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
__________________
FORM 8-K
__________________
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported): October 21, 2025
__________________
dhrlogo.jpg
DANAHER CORPORATION
(Exact Name of Registrant as Specified in Its Charter)
__________________
Delaware001-0808959-1995548
(State or Other Jurisdiction of Incorporation)(Commission File Number)(IRS Employer Identification No.)
2200 Pennsylvania Avenue, N.W., 20037-1701
Suite 800W
Washington,DC
(Address of Principal Executive Offices) (Zip Code)
202-828-0850
(Registrant’s Telephone Number, Including Area Code)
Not applicable
(Former Name or Former Address, if Changed Since Last Report)
__________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common stock, $0.01 par valueDHRNew York Stock Exchange
0.200% Senior Notes due 2026DHR/26New York Stock Exchange
2.100% Senior Notes due 2026DHR 26New York Stock Exchange
1.200% Senior Notes due 2027DHR/27New York Stock Exchange
0.450% Senior Notes due 2028DHR/28New York Stock Exchange
2.500% Senior Notes due 2030DHR 30New York Stock Exchange
0.750% Senior Notes due 2031DHR/31New York Stock Exchange
1.350% Senior Notes due 2039DHR/39New York Stock Exchange
1.800% Senior Notes due 2049DHR/49New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ 





ITEM 2.02RESULTS OF OPERATIONS AND FINANCIAL CONDITION
On October 21, 2025, Danaher Corporation (“Danaher”) issued a press release announcing financial results for the quarter ended September 26, 2025. A copy of the release is furnished herewith as Exhibit 99.1 and incorporated by reference herein. This Current Report on Form 8-K and the press release attached hereto are being furnished by Danaher pursuant to Item 2.02 of Form 8-K.
This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

ITEM 9.01FINANCIAL STATEMENTS AND EXHIBITS
(c)Exhibits:
Exhibit No.  Description
99.1   
104 The cover page from this Current Report on Form 8-K, formatted as Inline XBRL.



SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
DANAHER CORPORATION
Date:October 20, 2025By:/s/ Matthew R. McGrew
Matthew R. McGrew
Executive Vice President and Chief Financial Officer


 EX-99.1 2 dhr-20251021xex991.htm EX-99.1 Document
Exhibit 99.1
dhrlogo.jpg
Innovation at the speed of life

Danaher Reports Third Quarter 2025 Results
WASHINGTON D.C., October 21, 2025 -- Danaher Corporation (NYSE: DHR) (the “Company”) today announced results for the quarter ended September 26, 2025.
Key Third Quarter 2025 Results
•Net earnings were $908 million, or $1.27 per diluted common share and non-GAAP adjusted diluted net earnings per common share were $1.89.
•Revenues increased 4.5% year-over-year to $6.1 billion and non-GAAP core revenue increased 3.0% year-over-year.
•Operating cash flow was $1.7 billion and non-GAAP free cash flow was $1.4 billion.
Rainer M. Blair, President and Chief Executive Officer, stated, “We are encouraged by our third quarter results. DBS-driven execution paired with continued momentum in our bioprocessing business and better-than-anticipated respiratory revenue at Cepheid enabled us to exceed our revenue, earnings and cash flow expectations.”
Mr. Blair continued, “We remain intensely focused on delivering value for our customers, associates, and shareholders. We’re investing in breakthrough innovation, enhancing our commercial execution, and driving meaningful productivity gains across our businesses. We believe these efforts will strengthen our long-term competitive position and help to solve some of the world’s most difficult healthcare challenges.”
Full Year 2025 Outlook
The Company does not reconcile Non-GAAP forecasted core sales growth and adjusted diluted net earnings per common share to their respective, comparable measure prepared in accordance with U.S. generally accepted accounting principles (GAAP) (except for estimated amortization of acquisition-related intangible assets of $1.7 billion for the year ending December 31, 2025 and the estimated impact of foreign currency on sales, which for the full year 2025 is estimated to increase sales by 1.0%, assuming the currency exchange rates in effect as of September 26, 2025) because the additional elements that would be reflected in any such GAAP measures (such as the impact of currency exchange rates on profitability, acquisitions, divested product lines, discrete tax adjustments, impairments, gains and losses on investments and the outcome of legal proceedings) are difficult to predict and estimate and are often dependent on future events that may be uncertain or outside of our control. The impact of these additional elements could be material to our results computed in accordance with GAAP.
For full year 2025, the Company is maintaining its full year adjusted diluted net earnings per common share guidance range of $7.70 to $7.80. This includes an expectation that non-GAAP core revenue will grow low-single digits year-over-year for the full year 2025.
Conference Call and Webcast Information
Danaher will discuss its third quarter results and financial guidance for the fourth quarter and full year 2025, including as applicable key assumptions with respect thereto, during its investor conference call today starting at 8:00 a.m. ET. The call and an accompanying slide presentation will be webcast on the “Investors” section of Danaher’s website, www.danaher.com, under the subheading “Events & Presentations.” A replay of the webcast will be available in the same section of Danaher’s website shortly after the conclusion of the presentation and will remain available until the next quarterly earnings call.
The conference call can be accessed by dialing 800-245-3047 within the U.S. or by dialing +1 203-518-9765 outside the U.S. a few minutes before the 8:00 a.m. ET start and telling the operator that you are dialing in for Danaher’s earnings conference call (Conference ID: DHRQ325). A replay of the conference call will be available shortly after the conclusion of the call and until November 4, 2025. You can access the replay dial-in information on the “Investors” section of Danaher’s website under the subheading “Events & Presentations.”
ABOUT DANAHER
Danaher is a leading global life sciences and diagnostics innovator, committed to accelerating the power of science and technology to improve human health. Our businesses partner closely with customers to solve many of the most important health challenges impacting patients around the world. Danaher's advanced science and technology - and proven ability to innovate - help enable faster, more accurate diagnoses and help reduce the time and cost needed to sustainably discover, develop and deliver life-changing therapies. Focused on scientific excellence, innovation and continuous improvement, our approximately 63,000 associates worldwide help ensure that Danaher is improving quality of life for billions of people today, while setting the foundation for a healthier, more sustainable tomorrow. Explore more at www.danaher.com.
1

NON-GAAP MEASURES AND SUPPLEMENTAL MATERIALS
In addition to the financial measures prepared in accordance with GAAP, this earnings release also contains non-GAAP financial measures. Calculations of these measures, explanations of what these measures represent and the reasons why we believe these measures provide useful information to investors, a reconciliation of these measures to the most directly comparable GAAP measures, where applicable, and other information relating to these non-GAAP measures are included in the supplemental reconciliation schedule attached.
In addition, our Quarterly Report on Form 10-Q for the third quarter of 2025, this earnings release, the slide presentation accompanying the related earnings call, non-GAAP reconciliations and a note containing details of historical and anticipated, future financial performance have been posted to the “Investors” section of Danaher’s website (www.danaher.com).
FORWARD-LOOKING STATEMENTS
Statements in this release that are not strictly historical, including the statements regarding the Company’s anticipated financial results for the fourth quarter and full year 2025, Danaher’s long-term competitive positioning, and any other statements regarding events or developments that we believe or anticipate will or may occur in the future are "forward-looking" statements within the meaning of the federal securities laws. There are a number of important factors that could cause actual results, developments and business decisions to differ materially from those suggested or indicated by such forward-looking statements and you should not place undue reliance on any such forward-looking statements. These factors include, among other things: the impact of tariffs and related actions implemented by the U.S. and other countries, the impact of our debt obligations on our operations and liquidity, deterioration of or instability in the global economy, the markets we serve and the financial markets, uncertainties with respect to the development, deployment, and use of artificial intelligence in our business and products, the impact of global health crises, uncertainties relating to national laws or policies, including laws or policies to protect or promote domestic interests and/or address foreign competition, contractions or growth rates and cyclicality of markets we serve, competition, our ability to develop and successfully market new products and technologies and expand into new markets, the potential for improper conduct by our employees, agents or business partners, our compliance with applicable laws and regulations (including rules relating to off-label marketing and other regulations relating to medical devices and the healthcare industry), the results of our clinical trials and perceptions thereof, our ability to effectively address cost reductions and other changes in the healthcare industry, our ability to successfully identify and consummate appropriate acquisitions and strategic investments, our ability to integrate the businesses we acquire and achieve the anticipated growth, synergies and other benefits of such acquisitions, contingent liabilities and other risks relating to acquisitions, investments, strategic relationships and divestitures (including tax-related and other contingent liabilities relating to past and future IPOs, split-offs or spin-offs), security breaches or other disruptions of our information technology systems or violations of data privacy laws, the impact of our restructuring activities on our ability to grow, risks relating to potential impairment of goodwill and other intangible assets, currency exchange rates, tax audits and changes in our tax rate and income tax liabilities, changes in tax laws applicable to multinational companies, litigation, regulatory proceedings and other contingent liabilities including intellectual property and environmental, health and safety matters, the rights of the United States government with respect to our production capacity in times of national emergency or with respect to intellectual property/production capacity developed using government funding, risks relating to product, service or software defects, product liability and recalls, risks relating to our manufacturing operations, the impact of climate change, legal or regulatory measures to address climate change and other sustainability topics and our ability to address regulatory requirements or stakeholder expectations relating to climate change and other sustainability topics, risks relating to fluctuations in the cost and availability of the supplies we use (including commodities) and labor we need for our operations, our relationships with and the performance of our channel partners, uncertainties relating to collaboration arrangements with third-parties, the impact of deregulation on demand for our products and services, labor matters and our ability to recruit, retain and motivate talented employees, U.S. and non-U.S. economic, political, geopolitical, legal, compliance, social and business factors (including the impact of elections, regulatory changes or uncertainty, government shutdowns and military conflicts), disruptions and other impacts relating to man-made and natural disasters, inflation and the impact of our By-law exclusive forum provisions. Additional information regarding the factors that may cause actual results to differ materially from these forward-looking statements is available in our SEC filings, including our 2024 Annual Report on Form 10-K and Quarterly Report on Form 10-Q for the third quarter of 2025. These forward-looking statements speak only as of the date of this release and except to the extent required by applicable law, the Company does not assume any obligation to update or revise any forward-looking statement, whether as a result of new information, future events and developments or otherwise.
CONTACT
John T. Bedford, Vice President, Investor Relations, investor.relations@danaher.com
Danaher Corporation, 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, D.C. 20037,
Telephone: (202) 828-0850, Fax: (202) 828-0860
2

DANAHER CORPORATION AND SUBSIDIARIES
CONSOLIDATED CONDENSED STATEMENTS OF EARNINGS
($ and shares in millions, except per share amounts)
(unaudited)
 Three-Month Period EndedNine-Month Period Ended
 September 26, 2025September 27, 2024September 26, 2025September 27, 2024
Sales$6,053 $5,798 $17,730 $17,337 
Cost of sales(2,530)(2,397)(7,173)(7,021)
Gross profit3,523 3,401 10,557 10,316 
Operating costs:
Selling, general and administrative expenses(1,991)(2,060)(6,209)(5,736)
Research and development expenses(378)(383)(1,160)(1,142)
Operating profit1,154 958 3,188 3,438 
Nonoperating income (expense):
Other income (expense), net(14)102 (135)7 
Interest expense(67)(87)(210)(217)
Interest income3 4 17 103 
Earnings before income taxes1,076 977 2,860 3,331 
Income taxes(168)(159)(443)(518)
Net earnings $908 $818 $2,417 $2,813 
Net earnings per common share:
Basic$1.28 $1.13 $3.38 
(a)
$3.83 
Diluted$1.27 $1.12 $3.37 
(a)
$3.80 
(a)
Average common stock and common equivalent shares outstanding:
Basic710.7 723.0 714.5 733.8 
Diluted713.7 729.4 717.9 740.1 
(a) Net earnings per common share amounts for the relevant three-month periods do not add to the nine-month period amount due to rounding.
This information is presented for reference only. A complete copy of Danaher’s Form 10-Q financial statements is available on the Company’s website (www.danaher.com).
3

DANAHER CORPORATION
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES
Diluted Net Earnings Per Common Share and Adjusted Diluted Net Earnings Per Common Share
Three-Month Period EndedNine-Month Period Ended
September 26, 2025September 27, 2024September 26, 2025September 27, 2024
Diluted Net Earnings Per Common Share (GAAP)$1.27 $1.12 $3.37 $3.80 
Amortization of acquisition-related intangible assetsA
0.61 0.57 1.77 1.65 
Fair value net (gains) losses on investmentsB
0.02 (0.14)0.21 (0.01)
ImpairmentsC
0.14 0.30 0.76 0.30 
Gain on a product line dispositionD
— — (0.01)— 
Acquisition-related itemsE
— — — 0.03 
Tax effect of the above adjustmentsF
(0.15)(0.14)(0.54)(0.37)
Discrete tax adjustmentsG
— — 0.02 (0.06)
Rounding— — (0.01)— 
Adjusted Diluted Net Earnings Per Common Share (Non-GAAP)$1.89 $1.71 $5.57 $5.34 

Notes to Reconciliation of GAAP to Non-GAAP Financial Measures
A    Amortization of acquisition-related intangible assets in the following historical periods ($ in millions) (only the pretax amounts set forth below are reflected in the amortization line item above):
Three-Month Period EndedNine-Month Period Ended
September 26, 2025September 27, 2024September 26, 2025September 27, 2024
Pretax$433 $414 $1,269 $1,223 
After-tax359 341 1,053 1,008 
B    Net (gains) losses on the Company's equity and limited partnership investments recorded in the following historical periods ($ in millions) (only the pretax amounts set forth below are reflected in the fair value net (gains) losses on investments line above):
Three-Month Period EndedNine-Month Period Ended
September 26, 2025September 27, 2024September 26, 2025September 27, 2024
Pretax$15 $(103)$149 $(7)
After-tax12 (82)113 (9)
C    Impairment charges related to technology and other intangible assets in the Biotechnology segment recorded in both the three and nine-month periods ended September 26, 2025 ($86 million pretax as reported in this line item, $58 million after-tax), a trade name in the Diagnostics segment recorded in both the three and nine-month periods ended September 26, 2025 ($15 million pretax as reported in this line item, $12 million after-tax), a trade name in the Life Sciences segment recorded in the nine-month period ended September 26, 2025 ($432 million pretax as reported in this line item, $328 million after-tax), a facility in the Biotechnology segment recorded in the nine-month period ended September 26, 2025 ($15 million pretax as reported in this line item, $11 million after-tax) and a trade name in the Life Sciences segment recorded in both the three and nine-month periods ended September 27, 2024 ($222 million pretax as recorded in this line item, $169 million after-tax).
D    Gain on a product line disposition in the nine-month period ended September 26, 2025 ($9 million pretax as reported in this line item, $7 million after-tax).
E    Costs incurred for the fair value adjustment to inventory related to the acquisition of Abcam plc for the nine-month period ended September 27, 2024 ($25 million pretax as reported in this line item, $19 million after-tax).
4

DANAHER CORPORATION
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES
(continued)
F    This line item reflects the aggregate tax effect of all nontax adjustments reflected in the preceding line items of the table. In addition, the footnotes above indicate the after-tax amount of each individual adjustment item. Danaher estimates the tax effect of each adjustment item by applying Danaher’s overall estimated effective tax rate to the pretax amount, unless the nature of the item and/or the tax jurisdiction in which the item has been recorded requires application of a specific tax rate or tax treatment, in which case the tax effect of such item is estimated by applying such specific tax rate or tax treatment.
G    There were no net discrete tax adjustments for the three-month period ended September 26, 2025, as a valuation allowance recorded on certain foreign operating losses was offset by benefits from the remeasurement of deferred taxes in a jurisdiction which enacted a tax rate change. Discrete tax adjustments and other tax-related adjustments for the nine-month period ended September 26, 2025, include the impact of net discrete tax charges of $12 million related primarily to a valuation allowance recorded on certain foreign operating losses and changes in uncertain tax positions, partially offset by the remeasurement of deferred taxes in a jurisdiction which enacted a tax rate change and the release of reserves for uncertain tax positions due to the expiration of statutes of limitations. There were no net discrete tax adjustments and other tax-related adjustments for the three-month period ended September 27, 2024 as excess tax benefits from stock-based compensation were offset by other discrete tax charges. Discrete tax adjustments and other tax-related adjustments for the nine-month period ended September 27, 2024, include net discrete tax benefits of $45 million related primarily to excess tax benefits from stock-based compensation, release of reserves for uncertain tax positions due to the expiration of statutes of limitations and changes in estimates associated with prior period uncertain tax positions.

Sales Growth (Decline) by Segment and Core Sales Growth (Decline) by Segment
% Change Three-Month Period Ended September 26, 2025 vs. Comparable 2024 Period
Segments
Total CompanyBiotechnologyLife SciencesDiagnostics
Total sales growth (GAAP)4.5 %9.0 %0.5 %4.0 %
Impact of:
Divestitures— %— %— %0.5 %
Currency exchange rates (1.5)%(2.5)%(1.5)%(1.0)%
Core sales growth (decline) (non-GAAP)3.0 %6.5 %(1.0)%3.5 %
% Change Nine-Month Period Ended September 26, 2025 vs. Comparable 2024 Period
Segments
Total CompanyBiotechnologyLife SciencesDiagnostics
Total sales growth (decline) (GAAP)2.5 %7.5 %(1.0)%1.0 %
Impact of:
Acquisitions/divestitures— %— %(1.0)%0.5 %
Currency exchange rates (1.0)%(1.0)%(0.5)%— %
Core sales growth (decline) (non-GAAP)1.5 %6.5 %(2.5)%1.5 %

5

DANAHER CORPORATION
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES
(continued)
Forecasted Core Sales Growth by Segment and Adjusted Diluted Net Earnings Per Common Share
% Change Three-Month Period Ending December 31, 2025 vs. Comparable 2024 Period% Change Year Ending December 31, 2025 vs. Comparable 2024 Period
Biotechnology~+5%
Life Sciences-Low-single digit
DiagnosticsFlat
Core sales growth (non-GAAP)+Low-single digit+Low-single digit

Year Ending
December 31, 2025
Adjusted diluted net earnings per common share (non-GAAP)$7.70 - $7.80

Supplemental Forward-Looking Information
($ in millions)
Three-Month Period Ending
December 31, 2025
Impact of currency exchange rates on salesH
~+2.5%
Corporate expenseI
~$(85)
Interest expense, netJ
~$(50)
Effective tax rate~17.0%
H    Impact of currency exchange rates on sales for the fourth quarter 2025 is estimated to increase sales by 2.5%, assuming the currency exchange rates in effect as of September 26, 2025.
I Corporate expense represents the operating profit (GAAP) for the Other segment, which consists of unallocated corporate costs and other costs not considered part of management’s evaluation of reportable segment operating performance.
J    Interest expense, net is defined as interest expense net of interest income. This line item is an assumption rather than a forecast. The estimated interest expense, net is calculated assuming the currency exchange rates in effect as of September 26, 2025 are to prevail throughout the remainder of the period indicated and no change in the amount of commercial paper outstanding.

Cash Flow and Free Cash Flow
($ in millions)
Three-Month Period Ended
September 26, 2025September 27, 2024
Total Cash Flow:
Net cash provided by operating activities (GAAP)$1,662 $1,513 
Total cash used in investing activities (GAAP)$(312)$(606)
Total cash used in financing activities (GAAP)$(2,781)$(845)
Free Cash Flow:
Net cash provided by operating activities (GAAP)$1,662 $1,513 
Less: payments for additions to property, plant & equipment (capital expenditures) (GAAP)(292)(298)
Plus: proceeds from sales of property, plant & equipment (capital disposals) (GAAP)— 11 
Free cash flow (non-GAAP)$1,370 $1,226 
We define free cash flow as operating cash flows, less payments for additions to property, plant and equipment (“capital expenditures”) plus the proceeds from sales of plant, property and equipment (“capital disposals”).

6

Statement Regarding Non-GAAP Measures
Each of the non-GAAP measures set forth above should be considered in addition to, and not as a replacement for or superior to, the comparable GAAP measure, and may not be comparable to similarly titled measures reported by other companies.  Management believes that these measures provide useful information to investors by offering additional ways of viewing Danaher Corporation’s (“Danaher” or the “Company”) results that, when reconciled to the corresponding GAAP measure, help our investors:
•with respect to Adjusted Diluted Net Earnings Per Common Share, understand the long-term profitability trends of our business and compare our profitability to prior and future periods and to our peers;
•with respect to core sales, identify underlying growth trends in our business and compare our sales performance with prior and future periods and to our peers; and
•with respect to free cash flow (the “FCF Measure”), understand Danaher’s ability to generate cash without external financings, strengthen its balance sheet, invest in its business and grow its business through acquisitions and other strategic opportunities (although a limitation of free cash flow is that it does not take into account the Company’s debt service requirements and other non-discretionary expenditures, and as a result the entire free cash flow amount is not necessarily available for discretionary expenditures).
Management uses the non-GAAP measures referenced above to measure the Company’s operating and financial performance, and uses core sales and non-GAAP measures similar to Adjusted Diluted Net Earnings Per Common Share and the FCF Measure in the Company’s executive compensation program.
The items excluded from the non-GAAP measures set forth above have been excluded for the following reasons:
•With respect to Adjusted Diluted Net Earnings Per Common Share:
◦Amortization of Intangible Assets: We exclude the amortization of acquisition-related intangible assets because the amount and timing of such charges are significantly impacted by the timing, size, number and nature of the acquisitions we consummate. While we have a history of significant acquisition activity we do not acquire businesses on a predictable cycle, and the amount of an acquisition’s purchase price allocated to intangible assets and the related amortization term are unique to each acquisition and can vary significantly from acquisition to acquisition. Exclusion of this amortization expense facilitates more consistent comparisons of operating results over time between our newly acquired and long-held businesses, and with both acquisitive and non-acquisitive peer companies. We believe however that it is important for investors to understand that such intangible assets contribute to sales generation and that intangible asset amortization related to past acquisitions will recur in future periods until such intangible assets have been fully amortized.
◦Restructuring Charges: We exclude costs incurred pursuant to discrete restructuring plans that are fundamentally different (in terms of the size, strategic nature and planning requirements, as well as the inconsistent frequency, of such plans) from the ongoing productivity improvements that result from application of the Danaher Business System. Because these restructuring plans are incremental to the core activities that arise in the ordinary course of our business and we believe are not indicative of Danaher’s ongoing operating costs in a given period, we exclude these costs to facilitate a more consistent comparison of operating results over time.
◦Other Adjustments: With respect to the other items excluded from Adjusted Diluted Net Earnings Per Common Share, we exclude these items because they are of a nature and/or size that occur with inconsistent frequency, occur for reasons that may be unrelated to Danaher's commercial performance during the period and/or we believe that such items may obscure underlying business trends and make comparisons of long-term performance difficult.
•With respect to core sales, (1) we exclude the impact of currency translation because it is not under management’s control, is subject to volatility and can obscure underlying business trends, and (2) we exclude the effect of acquisitions and divested product lines because the timing, size, number and nature of such transactions can vary significantly from period-to-period and between us and our peers, which we believe may obscure underlying business trends and make comparisons of long-term performance difficult.
•With respect to the FCF Measure, we deduct payments for additions to property, plant and equipment (net of the proceeds from capital disposals) to demonstrate the amount of operating cash flow for the period that remains after accounting for the Company’s capital expenditure requirements.
7
 EX-101.SCH 3 dhr-20251021.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Document And Entity Information Document And Entity Information link:presentationLink link:calculationLink link:definitionLink EX-101.DEF 4 dhr-20251021_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 5 dhr-20251021_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Entity Listings [Table] Entity Listings [Table] Soliciting material Soliciting Material Written communications Written Communications Entity Listings [Line Items] Entity Listings [Line Items] 1.200% Senior Notes due 2027 1.2% Senior Notes Due 2027 [Member] 1.2% Senior Notes Due 2027 [Member] Class of Stock [Domain] Class of Stock [Domain] Local phone number Local Phone Number 2.100% Senior Notes due 2026 2.1% Senior Notes Due 2026 [Member] 2.1% Senior Notes Due 2026 [Member] 0.200% Senior Notes due 2026 0.2% Senior Notes Due 2026 [Member] 0.2% Senior Notes Due 2026 [Member] Amendment flag Amendment Flag Entity emerging growth company Entity Emerging Growth Company Entity file number Entity File Number Security exchange name Security Exchange Name 0.450% Senior Notes due 2028 0.45% Senior Notes Due 2028 [Member] 0.45% Senior Notes Due 2028 [Member] Entity address, state Entity Address, State or Province Entity address, address line one Entity Address, Address Line One Entity address, address line two Entity Address, Address Line Two 2.500% Senior Notes due 2030 2.5% Senior Notes Due 2030 [Member] 2.5% Senior Notes Due 2030 [Member] City area code City Area Code Cover [Abstract] Cover [Abstract] Document period end date Document Period End Date Pre-commencement tender offer Pre-commencement Tender Offer Class of Stock [Axis] Class of Stock [Axis] Entity central index key Entity Central Index Key Pre-commencement issuer tender offer Pre-commencement Issuer Tender Offer Entity tax identification number Entity Tax Identification Number Entity registrant name Entity Registrant Name Trading symbol Trading Symbol 1.350% Senior Notes due 2039 1.35% Senior Notes Due 2039 [Member] 1.35% Senior Notes Due 2039 [Member] Common stock, $0.01 par value Common Stock [Member] Entity incorporation, state Entity Incorporation, State or Country Code Title of 12(b) security Title of 12(b) Security 1.800% Senior Notes due 2049 1.8% Senior Notes Due 2049 [Member] 1.8% Senior Notes Due 2049 [Member] Entity address, postal zip code Entity Address, Postal Zip Code Entity address, city Entity Address, City or Town 0.750% Senior Notes due 2031 0.75% Senior Notes Due 2031 [Member] 0.75% Senior Notes Due 2031 [Member] Document type Document Type EX-101.PRE 6 dhr-20251021_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 7 dhr-20251021_g1.jpg begin 644 dhr-20251021_g1.jpg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dhrlogo.jpg begin 644 dhrlogo.jpg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htm IDEA: XBRL DOCUMENT v3.25.3
Document And Entity Information Document And Entity Information
Oct. 21, 2025
Cover [Abstract]  
Document type 8-K
Document period end date Oct. 21, 2025
Entity registrant name DANAHER CORPORATION
Entity incorporation, state DE
Entity file number 001-08089
Entity tax identification number 59-1995548
Entity address, address line one 2200 Pennsylvania Avenue, N.W.,
Entity address, address line two Suite 800W
Entity address, city Washington,
Entity address, state DC
Entity address, postal zip code 20037-1701
City area code 202
Local phone number 828-0850
Written communications false
Soliciting material false
Pre-commencement tender offer false
Pre-commencement issuer tender offer false
Entity emerging growth company false
Amendment flag false
Entity central index key 0000313616
Entity Listings [Line Items]  
Document period end date Oct. 21, 2025
Common stock, $0.01 par value  
Entity Listings [Line Items]  
Title of 12(b) security Common stock, $0.01 par value
Trading symbol DHR
Security exchange name NYSE
0.200% Senior Notes due 2026  
Entity Listings [Line Items]  
Title of 12(b) security 0.200% Senior Notes due 2026
Trading symbol DHR/26
Security exchange name NYSE
2.100% Senior Notes due 2026  
Entity Listings [Line Items]  
Title of 12(b) security 2.100% Senior Notes due 2026
Trading symbol DHR 26
Security exchange name NYSE
1.200% Senior Notes due 2027  
Entity Listings [Line Items]  
Title of 12(b) security 1.200% Senior Notes due 2027
Trading symbol DHR/27
Security exchange name NYSE
0.450% Senior Notes due 2028  
Entity Listings [Line Items]  
Title of 12(b) security 0.450% Senior Notes due 2028
Trading symbol DHR/28
Security exchange name NYSE
2.500% Senior Notes due 2030  
Entity Listings [Line Items]  
Title of 12(b) security 2.500% Senior Notes due 2030
Trading symbol DHR 30
Security exchange name NYSE
0.750% Senior Notes due 2031  
Entity Listings [Line Items]  
Title of 12(b) security 0.750% Senior Notes due 2031
Trading symbol DHR/31
Security exchange name NYSE
1.350% Senior Notes due 2039  
Entity Listings [Line Items]  
Title of 12(b) security 1.350% Senior Notes due 2039
Trading symbol DHR/39
Security exchange name NYSE
1.800% Senior Notes due 2049  
Entity Listings [Line Items]  
Title of 12(b) security 1.800% Senior Notes due 2049
Trading symbol DHR/49
Security exchange name NYSE
XML 11 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 12 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ .report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } .report table.authRefData a { display: block; font-weight: bold; } .report table.authRefData p { margin-top: 0px; } .report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } .report table.authRefData .hide a:hover { background-color: #2F4497; } .report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } .report table.authRefData table{ font-size: 1em; } /* Report Styles */ .pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ .report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } .report hr { border: 1px solid #acf; } /* Top labels */ .report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } .report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } .report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } .report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } .report td.pl div.a { width: 200px; } .report td.pl a:hover { background-color: #ffc; } /* Header rows... */ .report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ .report .rc { background-color: #f0f0f0; } /* Even rows... */ .report .re, .report .reu { background-color: #def; } .report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ .report .ro, .report .rou { background-color: white; } .report .rou td { border-bottom: 1px solid black; } .report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ .report .fn { white-space: nowrap; } /* styles for numeric types */ .report .num, .report .nump { text-align: right; white-space: nowrap; } .report .nump { padding-left: 2em; } .report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ .report .text { text-align: left; white-space: normal; } .report .text .big { margin-bottom: 1em; width: 17em; } .report .text .more { display: none; } .report .text .note { font-style: italic; font-weight: bold; } .report .text .small { width: 10em; } .report sup { font-style: italic; } .report .outerFootnotes { font-size: 1em; } XML 14 FilingSummary.xml IDEA: XBRL DOCUMENT 3.25.3 html 10 23 1 false 9 0 false 0 false false R1.htm 0000001 - Document - Document And Entity Information Document And Entity Information Sheet http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation Document And Entity Information Document And Entity Information Cover 1 false false All Reports Book All Reports dhr-20251021.htm dhr-20251021.xsd dhr-20251021_def.xml dhr-20251021_lab.xml dhr-20251021_pre.xml dhr-20251021_g1.jpg http://xbrl.sec.gov/dei/2025 true false JSON 16 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "dhr-20251021.htm": { "nsprefix": "dhr", "nsuri": "http://www.danaher.com/20251021", "dts": { "inline": { "local": [ "dhr-20251021.htm" ] }, "schema": { "local": [ "dhr-20251021.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd", "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd", "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd", "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd", "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd", "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd", "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd", "https://xbrl.sec.gov/country/2025/country-2025.xsd", "https://xbrl.sec.gov/dei/2025/dei-2025.xsd", "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd" ] }, "definitionLink": { "local": [ "dhr-20251021_def.xml" ] }, "labelLink": { "local": [ "dhr-20251021_lab.xml" ] }, "presentationLink": { "local": [ "dhr-20251021_pre.xml" ] } }, "keyStandard": 23, "keyCustom": 0, "axisStandard": 1, "axisCustom": 0, "memberStandard": 1, "memberCustom": 8, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2025": 2 }, "contextCount": 10, "entityCount": 1, "segmentCount": 9, "elementCount": 37, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2025": 47 }, "report": { "R1": { "role": "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation", "longName": "0000001 - Document - Document And Entity Information Document And Entity Information", "shortName": "Document And Entity Information Document And Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhr-20251021.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhr-20251021.htm", "first": true, "unique": true } } }, "tag": { "dhr_A0.2SeniorNotesDue2026Member": { "xbrltype": "domainItemType", "nsuri": "http://www.danaher.com/20251021", "localname": "A0.2SeniorNotesDue2026Member", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "0.200% Senior Notes due 2026", "label": "0.2% Senior Notes Due 2026 [Member]", "documentation": "0.2% Senior Notes Due 2026 [Member]" } } }, "auth_ref": [] }, "dhr_A0.45SeniorNotesDue2028Member": { "xbrltype": "domainItemType", "nsuri": "http://www.danaher.com/20251021", "localname": "A0.45SeniorNotesDue2028Member", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "0.450% Senior Notes due 2028", "label": "0.45% Senior Notes Due 2028 [Member]", "documentation": "0.45% Senior Notes Due 2028 [Member]" } } }, "auth_ref": [] }, "dhr_A0.75SeniorNotesDue2031Member": { "xbrltype": "domainItemType", "nsuri": "http://www.danaher.com/20251021", "localname": "A0.75SeniorNotesDue2031Member", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "0.750% Senior Notes due 2031", "label": "0.75% Senior Notes Due 2031 [Member]", "documentation": "0.75% Senior Notes Due 2031 [Member]" } } }, "auth_ref": [] }, "dhr_A1.2SeniorNotesDue2027Member": { "xbrltype": "domainItemType", "nsuri": "http://www.danaher.com/20251021", "localname": "A1.2SeniorNotesDue2027Member", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "1.200% Senior Notes due 2027", "label": "1.2% Senior Notes Due 2027 [Member]", "documentation": "1.2% Senior Notes Due 2027 [Member]" } } }, "auth_ref": [] }, "dhr_A1.35SeniorNotesDue2039Member": { "xbrltype": "domainItemType", "nsuri": "http://www.danaher.com/20251021", "localname": "A1.35SeniorNotesDue2039Member", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "1.350% Senior Notes due 2039", "label": "1.35% Senior Notes Due 2039 [Member]", "documentation": "1.35% Senior Notes Due 2039 [Member]" } } }, "auth_ref": [] }, "dhr_A1.8SeniorNotesDue2049Member": { "xbrltype": "domainItemType", "nsuri": "http://www.danaher.com/20251021", "localname": "A1.8SeniorNotesDue2049Member", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "1.800% Senior Notes due 2049", "label": "1.8% Senior Notes Due 2049 [Member]", "documentation": "1.8% Senior Notes Due 2049 [Member]" } } }, "auth_ref": [] }, "dhr_A2.1SeniorNotesDue2026Member": { "xbrltype": "domainItemType", "nsuri": "http://www.danaher.com/20251021", "localname": "A2.1SeniorNotesDue2026Member", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "2.100% Senior Notes due 2026", "label": "2.1% Senior Notes Due 2026 [Member]", "documentation": "2.1% Senior Notes Due 2026 [Member]" } } }, "auth_ref": [] }, "dhr_A2.5SeniorNotesDue2030Member": { "xbrltype": "domainItemType", "nsuri": "http://www.danaher.com/20251021", "localname": "A2.5SeniorNotesDue2030Member", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "2.500% Senior Notes due 2030", "label": "2.5% Senior Notes Due 2030 [Member]", "documentation": "2.5% Senior Notes Due 2030 [Member]" } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "AmendmentFlag", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment flag", "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "CityAreaCode", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "City area code", "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ClassOfStockDomain", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Class of Stock [Domain]", "label": "Class of Stock [Domain]" } } }, "auth_ref": [] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CommonStockMember", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, $0.01 par value", "label": "Common Stock [Member]" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "terseLabel": "Cover [Abstract]", "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Document period end date", "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentType", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Document type", "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity address, address line one", "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressAddressLine2", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity address, address line two", "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity address, city", "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity address, postal zip code", "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity address, state", "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity central index key", "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity emerging growth company", "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityFileNumber", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity file number", "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity incorporation, state", "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityListingsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityListingsLineItems", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Listings [Line Items]", "label": "Entity Listings [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_EntityListingsTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityListingsTable", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Listings [Table]", "label": "Entity Listings [Table]", "documentation": "Container for exchange listing information for an entity" } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityRegistrantName", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity registrant name", "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity tax identification number", "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "LocalPhoneNumber", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Local phone number", "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-commencement issuer tender offer", "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "PreCommencementTenderOffer", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-commencement tender offer", "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "Security12bTitle", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Title of 12(b) security", "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "SecurityExchangeName", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Security exchange name", "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "SolicitingMaterial", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Soliciting material", "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StatementClassOfStockAxis", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Class of Stock [Axis]", "label": "Class of Stock [Axis]" } } }, "auth_ref": [] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "TradingSymbol", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Trading symbol", "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "WrittenCommunications", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Written communications", "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14a", "Subsection": "12" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" } } } ZIP 17 0000313616-25-000180-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000313616-25-000180-xbrl.zip M4$L#!!0 ( /:,5%MZ*U#1.A( )6D 0 9&AR+3(P,C4Q,#(Q+FAT M;>U=:W?B.)/^/K]"R^R^G9P3&U^Q(0GO80C=PT[GLD!OS^Z7.<(6H+>-S<@F M@?WU6Y)MPL4D)B$)T/2'F6#+4JFJGJI2Z7;QS\G00_>$A33P+S^ILO()$=\) M7.KW+S_5VO5F\],_J[]<_)LD_?E;ZRNZ"ISQD/@1JC."(^*B!QH-4#0@Z'O M?M![C.X\'/4"-I2D^+-Z,)HRVA]$2%,T,RV6OF45TRDY)44Q)>)H/E*FE72+(718&432J M%(L]'';E@/6+R8LB)[J0%)YTF4=G11\>'F3^1!37%$4O4C^,L.^0I/Q"R0== ME%/+Y7)QP@E(*W7)8Y6BNI X]0D73S%BV \Y]W$$ M\N2?*Y*B2:HV:VW %BIQL8\'A,E.,!2-J8JFSC4H 3$+Y5/BGFH3A*38DJ[. ML\U=ZF3"LU(Q?ID6A4I_/,%@_KJ+0S*K>:7\ IOYV\?.K*M7U>=Z,ZLYI%GU M A5J\<_KKVUG0(986A!XQ<. F0+QI6_M0O5B0+!;O1B2""->CT3^'M/[RT(] M\"/ C]29CN S)_YU68C()"H*M2A6?_GEEXN(1AZI@K2D5"H7Q?C913&NN1NX MT^J%2^]1&$T]WP"&&77BYB=1 MB_0N"XX$ O/QD-=$:*4&*'R&Y*"Y4M$&]#1^Z M,:U#Q0Q[3=\EDS_(=%:_5:@J\$]7]9):6FFDN-@11GJ$@;$B80;[N>PKH1 3 MD(&$+E0B8/IE(:3#D<=E)IX-&*=RGM/R)'1!#**YQS:2)L-@S,0O80PJ24\% M_;RGZ7,BNIG^HB[_W:.$(4$2R<14O?G'8O>7/ZZFCQ9K'P%W C?]!1K)HBNP MS57>'TE5)*X[R^]F9+IKBJ9OTM]I(\6%?F>S07MK-B2](7VNH/%/%QJ;C#SJ MT.B:#+O0A$OAK7!KA<285]H1=(E_4_=P&-[VVE'@_*A-:%BHID7JP7 8^.)% M7,]%,;/Z&2=F5.R';/0]E V LU)39*U-?!JPFR BX=68 %]*!RDB8U]%I,GJ M3R(BE=HXS1+V:-^O.,!$P@KQQ^E[)_ "5OE5$?_.>]!)J8>'U)M6/M48 MQ=ZGLQ#[H10",WKQZY#^'ZFH!I E?C[$I%KP-4^%I:2K&B?VVTVST[A"[4ZM MTV@O4KHS-+8;]6^M9J?9:*/:S15J_%G_O7;SI8'JM]?7S7:[>7OSWH2793,7 MY=]Q.*!^/PK\,W0EUV6D*:91WE5J_UKYMY;2(69]0$$4C$#IH?*/59#/MZUK ME#]/F4YTQ'G:.#T)0+>E/Y;3DNBP1%5Z0TFIN>@&(+<:-QW4:MS=MCKO;F_R M$7DW9N$8^Q&* M0F#I_Z^,>O:DDY5W44,*2:)^XI"GI\:FQ'>P!4CQF-* E1 M8^(,L-\GJ.9$G&BUK!O[H2OUIY M@0FX$R%$(PXL"BB>ZH+ 8!)57'@B#:&* ?],ODZ!+TY71)!8)!2$7GZ;>7$-\ MA+L>25)3$1R^AN5R6;5/GL6($06GDI@TG M8:0,TBFN/M=T&%-EOU)D-?/YNJI,1=;*VZD*J%)*3U=5%+V,>PJ\Y#IV62C/ M-&"$7;XFH:*-)DC-DL\R0V->;LD8V<]A)0[J-YP%;9$^#?GT>70#;U*+H8-5 MJ]W4?F^T('AM@0NL=43TNL9>1.X:WNDKO%,XYQ(9/%'L0UB]N MQD!LLA+#8Q,[IEJR4;*V8GQ40R[9Y>W8,;#)96,K5>FZ;#YCJ#-A7=HOO&YJ M$YN^$S (UL1B(I&:J@=C/V+3>N N!E]\;1+/#$5DQ()[7L]CU&6 #24>?L!L M=:E*?E.0F[& K=WFZF?J$2@,46C*(9.G$U5)L16[?&01L*B#)\TDF^H(Y5OD M5ZE0-Z)/R9GZ$;^+I]MU\I[I+<2_'T$"^.LRE-]8<'#7HYT7J@<=P'$1-[_ MTE$<,,7:88-V*(IN2:JEJ'F\UTKB99M0V_E88!5G6LK)LD[P,(OC^:SYW/S8VYNP?6&5B,]NV1V,?*C8 M@)#P2X6!3WV+:KF_F#]).,7#U3L&3*(C[*'&A#CCB-X3=-N# (B$KXSO]L<- M[H_@P'@WIBK,N+L7%*8 M?9CKD+>-(J9HNE_'93R7D-STT0(3SB"]FX5)=6 M9!U,9N=SP #_R00*0\G/Q%F>(=KCDR9^G[BHS2,+]!6'$6J)^?--#/(B)MYP MHT9=$% 4H) .QUZ$?1*,0V^*0AS1L#<57R8?!%U@.4X3=_P%>YPS M&T,]#&%_FK[K@:$+'OAW/*E.>38L1"'H[3NC$<"6)YG'?I)Y#5?GL[I!X'4Q8# "2S"+X@P>X)-AL3Y@#U\]Q!H[DU=JTQ8,?0S,1D<5LUMX"-KUL[42U4_]Q"FJ[( M4/ %SNH(U2-4 :KM0.QE@/Y<@TOF3>?%J7G@.'WD#!HFK%D%J6I@&-'.X71A M=>D,I0:HEBAY!.H1J"\#ZATCW)_RXSG$4GT>%;/;7H_G/_(!MG3@@ 4.2!IR3+W9OLP5<_:.F8FYX4^7+=ERW[:S.9>/&S+AI+]R<8K?D&RZM-+FO?)^&?GESO\D+IX M!Y8S0 [?4OX6LY(?TC6&Q7Q3>SKL!M[):Z>.=Z=CZ68*(3*2^@DP' \#"D\> MKKWUI$[J6*ET5F\$6PYZN687-S@H"D 6_* M_B=@/Y XL6,6X&UCI]B^@E;/ UI-+50568/:4'RP"1(GFR!W3/C6W(QS1W\" MK=2?Q:RF"&OD@JU1J&JR>H3M6LYEP]84L$5'!KT"MJ4C M;#-X:^:"K56HJNN]K?53:J7Y/&SMQ-L>&?1RV):/L,W@;2D/;'6%!\F&N0:V M3V^!/52M+#T+6UU-8'MDT(MAJVM'V&;PULH%6YT'R>8:;ZNO; +X*;32>AZV M1APD'QGT"MB:1]AF\-;.!=L2][;6&F^K/[UE]U"UTGX>ME;L;8\,>@5L[2-L M,WA;S@7;,A_;ZNM@^RX'Z^PVYS)A:R@);(\,>C%L#?4(VZSE94H>W!H:QZV] M)DHV?DZU7&1=-G#U&+A'#KT&N<8KD)M_8>T[KD1K^BY?BDA0=XH0A@@H(]##/E]-TV?!0S3@*QI'?!\B!A22'C0ASO",=_TH9KIX M;6G+3WQ4M3Y;SLA/0;#.Q08@Q3SEVUOCU9!:5](RJL@Z]GJY+KY DG]^*A_Z MYG)-DS55WVBEV_KGIKY93>N(L@S9-I\^<'/_/5HC&PLO.;9E;WFPZ3DX*<^^ M");58X[E7"]NY-RGM<,6M_>$#3T#RYEID.G*_N\!F%OB$8??Y.T'8M'P."2B M%' _V67.[W<6:[51?)D.9[)HRYORQL4-X-QT^^#4X TC]S2$[\"(8]_A6\2P MX_ S7'EA?E^RBYD;QOO+W74KEO43/%NQ/&^FY?B@FT1Z2Z?>Y))0UKKNM=^L M/;1@HUKR?;,[:^KS7WW$+_#;L77X2R[X7^,PHKWI1_C@%YS>KRJRHFWGU&O; MDBWK:2>\7<_Y[@=%-3N-Z^12#9F?GK3MG3[OWJ%6H_WM:Z>-;C^CV[M&?.Y_ M?)W5Y^9-[:;>K'U%]=N;JV9G_CJKC3R5^=Z>ZM9'F?>?G*$K[&,^/*@_GB2, M3OB!3YIRGKP3O]3S4Q@SA&-P%1B\!C_2#4PBP>"GL.^#8W&X8WGT-E!B[$6A M\%+248G)DA&J@,J/IXR$I<1,P6NF-F4_# 7P, M))'8W?'!PX!V:80 Z"H0PH/$9]:&)S@"JJX\9XWNXXC-U M^#+[V1DOO!K>^%(OHP@[:?/@)#$#QTY$IV>407LI/^?]:1/ZBC@Z>+?29G*- M9,KOK2B"-]2/ SBN"^$ XC81E70)C DAV'%1HAX]ZA$W40XA9^@S.#\B#ON; MQ1!VSB'?&1?^A4LC0)1Y^2V!@&7:B2C@>@FY-CXZ9C[-E;4L76]B&;"BEG\/%EV5^ MO4./CESN71@BJ^<8GL6]Z+.Q. MGDR!1%Z7T[52/L^5X14*'T1$/#5^+FH0;XJ+#M:QXX1T7B^6U M3)U2T,[:5SX:RM:J;&R(GBBY^K'/V>T-X?:*HW77=JO7VW:W8K)0V)B>?Q1=:,#XC,+\Y:,3,BF757D0#<4Y*W/C;G'XM':.%G,2 MR;@]Y(-YYJ+_2K(+O#IX)5(/R5CQHHB7\Y9[Y*;WSO2HBO%1EF?_I]\Z P*4 MW_/T$>X3U&/!$$5/9ZO.DLDVG@/!(6J*<3GZ\[?65SE';O)@IT3XD?L[,2?R MP:?XMYM?;FJ=;ZU&>R?3C?/WM\?YWK_'E(G3M<+<>4->J+4XF^J.O2ER\)C/ M@ H )3>30S-=@D*0!KP %,'H#1X,L-?CN3M>D?!220&>Z1W[\(VH#H^C0<"@ M=VZNU&UZ+]H>I-5,63>V7K+._5W!GBMOM,-'-DW5?;;MLX$'W/5[!Z M7NKFBVPC@0A*6>Q$[B^@X"E/*-L%3N?'][@F?-R>75U_0+CKW_?WZ$; MGM8E,(5>"R *,K2A:HW4&M 7+K[31X(^%D3E7)08+RWL-:^>!%VM%0K]<-*% M=5ZQF*33=.K[$PQIF.-Q%*8XB2#"49;!>#89@Q_-_EHM0G\VFOG!!(< "1X' M2823J9_@,)J&40KIW$_ )MW*A4S74!*DJ3&YV,K862M5+3QOL]FXFY'+Q,?8#/-(S$:4$36H%;_3ZWT!. MZD+%3LW^K4E!D!%F1%(;9+:\0,DM.RXH+A=@1 M,BB98ZW!(\B?&@4+*S8&-QMS)SO,$*^M;Z M5!DG(6:$.QPV)AR$>M%_NX:=ELZKH(]Y-WV/-KZ[4$1S.=S MSWKUSK1@(E+!"^@/]BK!*Q"*@GQ^;-@$:P%Y[.C# W?;Z%LEP-6%=!%'^?>% M8-QZ I!Z)UNZ=SL^70K3DMB1N@T%-"MTP?0SR,^EKR&4T?\#^8(DYY+7$"C. MY&V #]J/:!8[W37^BF7_,$75TRTS=[854Y_/02;-Y_O;G]X,MK[?3M^5W!6] MZ_+2M[\ X=T;Y-FGSH::=.A9OB'_M7 U8,6Y+=7OAM^ D:Y>,\5R)L: MM$2G[Z!,0.BW12*5(*E^+BA1:SF;@SUV^C&,%EJI1LX-QKZ!%GIK4)X]6*EF MM6AU)6L] 56U&;T5O*YBIPFG"DK],&G"NT?1(N,EH>Q6^TRBW15P1"IT@[-) M]6(N@51P8M6C 5*]F$L@Y;OCR5&%LT']]8$N@5;H'A4X\@<%V(.Y!%*^&QU7 M& SVJ@]T";0"=W17\W?@^75#U!+ P04 M " #VC%1;[<>'U?\% "3)P % &1H&UL MU5K9;MLX%'W/5WC<2WW^X29/13RC*.,\.QF2"QR/(;.[B;'XP_G[^ M-PK''P[W]M[_@="/O[Z=CHYS>Y5"5HT^%J K<*/KN%J,J@6,_LV+B_BG'GU- M=!7E18K087/;Q_SRMHCGBVI$,>5MM_9JL<^ML )CCL#2"#%)+3(2))+. 0LY M RS#/^?[%(=!B E'%, @1HQ$1F"#J!146K *&V@&3>+L8K_^,;J$D4\O*YO3 M@_&BJB[WI]/KZ^O)C2F225[,IQ3C8-KV'J^ZWW3Z7P=-;Z*4FC97[[J6\;J. M?E@R_?'Y],PN(-4HSLI*9_8^@ _OJKL;'Z+AT^5%W[6,]\OF_M/H[8;J)D0H"LCDIG3CP[W1:,F<+FR1)_ -HM'J\/NW3UVD<59-79Q. M5WVF.DD\XF:$ZO82#L9EG%XFT+8M"H@VHF]3KD'Q&LZ[>K1I;TP+#Z2P5]X7 MOA6RVN(#8EPW>G_,=V,A!Y&^2JH!$7?''A1OGNIX2(([0P^ MAD(I9 :*(:$ M^FCD%%!.;I],&7;NV'F7N)*OBZO935B^DS=1_[MK+B;A% M@>K5EV#:S/=WKP[U(#=OHCB+Z]93?[J*5R?R.[*$FPHR!\N5JT64Y/91IZ1> M-_,[H1-M(&E:9P[BV3+":5Q6?K,K?0[PJ8*TG'%.- 08$%%:^0U),J1L2)$B M@3(NH I"T_5)V?JN!#N9YS^G/L2TYKP^:,A?.F5SX"6W0^1RKDT",T>L4YIC M1!QW?L?$D=\QP:% ,"J9XHJI-7Y_=1Y-T,Y86#PI=1_E*S0NS;)"_!'8RKX@KN&_.L\OX]2:#VNI^Q,*\/ M7JO_58GF6E_.SBI?D-4#?4QT6?X3G56YO3BZB!#.@0Y[9WY]SS"L4SM^"Z76^ MZ6F!AWB.FSUI*T2S)[7&0![HHAE0_(V%TKWT \N5OPG7O\<%BF'%)"B$16@1 M4]JBD'% 4K,H4I$"3<,=5?]1V?D_BO\K%+^%Z'F:YED#Z'-3ALZP!M"2:13P MD"$F*$9A% *RBE B.3B"Q=":/P4QI.3K:O>NWGV5>2IT+UJ[.N-75WF+8G:$ M)_0,LC@OON05E,=7X!40*UR:.BPL50$P3:B/A-CMT4= MBKRNJ$'/Y9?Q#K"PW1(A,*EII(C3VZW &V/LMJI# MD=<5E?>F(@(TG4E%T5<4RJCP/MMN\FZ.@"4RM@1CL58:L1H5"GRR0R6C D! C*.%8BPMMMK9N#[+:N@]'7 MU57VU#5\BHNUN(1A5#GET8#Q?C/^Z4L;3!&W(:/<<6'=EA73QAB[KNHPY'5% M#?M\EC@#>U7$U2VAYCRN$IB%ONXVDC>/6!@Q#PP9B3'27&AN \:8=+V^23R- M^/MD?8M/$[WX&_+E@\=R7NCZ7R%GMZG)DQGVSU0!I00)JCT081DRQ$,*%!;$ MFHB+2/82\E&XW5;Q]9.]85S$"$41 (CH* M@G^B\OMX*&2$;,"IQ1$8X_I]QUX;=K>5[<_DQG<.[Z=/&/%H+P[W5LWU3_W' MK,.]_P!02P,$% @ ]HQ46PAE]_DS'@ *" !, !D:'(M,C R-3$P M,C%?9S$N:G!GG7AW6%-?L^Y&FO0:$*0I($B5#@J)BG01$2$4(2(=1)KT$HJ M(D6Z($6Z2HF"=$Q$FDB3+@&! $J7!"0$TFY^WW/NO7_<6?-.S-K47]0EP%N4T,30X".C@ZX3WL ZCR@#]"?.O7/2Q,&VLMXFI&1@8&1 ME9F9Z30[*SL[&RL;&P!,:SL H(GA$2EKX@(WM13EU#4TM;Y[+^ M#0-#(V,34ZN[UC906SM[%UOOZ![X.?IN8G)J>F?TQA\:LK*[] M^KV^L;F%VS_X>X@_(AR?_(.+#J"G^]_RG^+BH>$ZQY@00\"QUD%I-0QTKA_H/T+V;\' M+/Y_A.S_ /N_N- ;?=HFT?/ T (A3_#B?3ATA&L^",>HBOKGP2F]!#IZ6V MF"E@9=>&DR&J+GOL;@$EAB&D '$2/_T*'E.L;^:\\7@-,65X^YMUK)SA:3V. MF&#*'+Q1%LLPZW09ZXL@606!M\F:("KP(E+\V#,6/L0;":?3C:KY17X5ASM6 MDC-3&/&?6ECJU@(ACER)^.B0Q=FM\N4EA,5B2XVF5 MMT&L,:$"\87TS<'*R03*WY8.Q+[A@M]@^!%)7?I03'EF,V+,?7%4_LG("V;X])ZL;/D!C!O6,7] M5EQ5;E%JR,Y4[JYF:4BF=>3AJ/SD8QBOEYA4PNB$AH/B'1&/X<8VD_R#.SZX M:]XC:;_Z2X-$1^KVT0N&@=G7?XE:O)',A,FD8%M9Y+N4+EA2 =X[I/9;S3U_ MMY0#*YPZJ$ F,< @QHH@CV\GO%U.R^Q>>7;H8#UP GY?OL.S^8GB#TZ57R3Q MT'PD E[M6VLO&(5#EO^ MBC!!C 9HWS/DK*AZ5HU1&E&G GSK\I:UR?G2MFW($5O9\I1?*JRRY;'_EJ9L MS9R=]_+]6&L*$V<+ZP M1S]_81UWNOI??YAT<^E]"%\O@ 1G$&N*!(X+47Z'N\P6.,/GD95;+9E+7JV9 MZH("!^QU3WL8Q'%;\OL(_&MRD1^%CM CL.(PQNK-.5:]=&G0Z3<+U]%4*.7< M5XH$:DJ$I5\/_<=O+@H[#WFW>4+6^"S@Q:R4[XCI6WO,UD/6%(FNSA'U?T\8;8T_0+HJ5"OB4/H6P MK:5P[6KB.%^T6=5LC4[$5C2:% \.W#(E"N/\/W9:5(7_6. 45*G<6-E\.] $ MR_>[&]'XY7:__MR*1&47%:CGFE*.IP+-^?$4%77-4RZOPQ*QD,:]-03>0BE&^:?@^?0UCD"N,PNB35=(#I M_5SD&Y M^16U_>K"$&<#_COU)3ASXFP^::>\725DIW!3XT.3Z^VS@ID=7/6P)W&@M=MK3E1XQU%-/[,B@A3 MD!BQ"S6]MI#%*]"D;$Q3&"\]*D=2<4>B M'PV,CQR8B$::4/U1;OH1.2D8WK8-K..1_E#6^ M'(+:"\=EU1N?["B$9[R%/UA":\)/;]LLTN- \^ $^(61RUX.SR_^*+H0*9G] ME_W::I P\00ED&OZ7F(Y_9IH[5\J@+<@U,OT63R9R78:GO01=B#'XWZ&%+"^ M<0W88GU_MK.Q.89N19SKRY,\WR2;.R&%!YO*)6.C8[40$1SSN9K$(K6;EQM? M?>32\?&[%U2 M*0:Y@4ZSLRPLLN@=<@A4Z?.:GR="43'3I73,7TK%]2CYODT]EX?4\66"OUJS MZUY$ K=^40'7U>+JKA VI2+H(9Y/HZS V?GYZSVAVI-0BQ$](7Q. &OEW8JI M&@Z$J-P$FOC@HW,3OM;,8]?4.B.2R\%*RL'*?DFTUF:R>^GEJS/FS,W1X52 87.J,KNWE'N'7\VA MQZ6JLWA)SM@-N2I65PE?@I@>FVX8>+%G+QB_=^BM6LOMD(O+@I_\-(\NH"V< MPZ9-B;-WF:\^[PU#812FM>P&)-;L'1+X[8[&7NKA$V"@ 1!&)+ZQ%!U@-EL M&=2,LG@JE C9.0DS(TYDP:7A!R2A0S*_)6Q(YF#CWR'5?RA=?Y03P<\+!_U\ M.2\ND,<],VK>I C^MNUV"&125P3.=FD/5CB+%.\8;Y:O9?MAS]9I9R]4_NC= MEK'D >BD'29"F:'5")?Q+A^?E2MWV9@:G]QZ!][!Q;+\/9N#6*GS.;S%/"J= M7*^ K#CRJ(NJ;"7.KD6$R8UR91Z"_9(&XOKL'/@V'?).P@9.U6F6-D= =WA[ MMZ(UA$^*YNV(=WGMB5 CQ6JYU)G#@/J@K??-PRR*A,V[2GE7PESSH,;E:69= M69>LK45-9&+E(&?##O2QUU6W!!T0FG_,SL1XO8I+S5AFEOCUH3^@)'<%YQC6 M@T_!-11@'$]]'E1<([1,WI=YL*J3!=UK#C03 =1B58/^./L?O&6VKUBKSETH MF=DC>T98'WRSE07#(AP[HD;W/I> IE'>?BD='K$DE74##!70\)@.EJBZVFK# MN*8C(KOQ-.8 )"/B2Z:5Y*3'2XP$OYO?'T>Z-DW\G7_:+'H.)^KME)N)NTW>Z.IAH34 (SBA/LBJ-ZB;[30.&Q5QZ_4? MQ9DF\9$7_7["P%'H&R"[$!WK:E+A"O*F!](8/$%2F]EOSVOK5CK*1D6W+N$O\(1%IH&5@Y#] \I0-$5 M/:['3-^&PV_G:A_;_SB2/5C<.6'K+P5U M*2[OJZEDL8TE2J0>+2@ M1?[X>?[KJB=#1.%!OOT>DIE$C[/895R5_2C.84]ZEMPUY<[@,-=KL12T/9"W$M =9=JV7@P+Q7MA6_.!#"N962,WU#C\:?',*UG?9<1>5<8:43/%J$S MX+_][RDH\.'+R[[,X*!T$[TBKI"L'VD>.Z3']^VY5ITLLFY<8?QW\3G>VF]$="O MJ(_,NT$KI<^A@O;NF>H446P%_9G&1)SBMR,U[;4$\N<0O,XV3&?HD<_1P^2> M1-E^9( \;,>("CS*WT >=&@'@R*2.Z-LR)U(:=)57O0F-( N?DP3BP[T_\; M_)/.<1P5"/*-FGOG^-,[/]MQ<6$D/%A-,"M\3>E/[UJ>RZ#44?U%1?*[NA;* M-#$)EK<$U?XD=<_66!AO/# 1D*O\,#,U<[B#:CS::7T7\WU1 MSD^C(DT]X]:KT619G\-#G>#X_.B41_%!\Z),C]<6PXF^Q.L ML/D]$$;2.1_,&)O7IIO;Z>$L$:$&UP%54[)=QMIE #C5',6W7,R'64IZJ O! M[((5U4P:+93.AAG]'HYHXAND(KZVY6IYR@$)KH"%S>RL)\B W;,L;_8O=S#M9![#2HH%R2UB!./:&X_4_ M5. +2B!F,DAC=.CG%;_BMSY,-5#9&UV>_H_+^D'1KO'HJLDHE!:IJ ^-*1D:!K\,8SHKF] M9>JA^Z41H4/1TX<,]Q,6N'V$7H_ W2;KA3.M$CHBJL-?+HS.OPRT7V^VSIM% M=P@TX]](-8UY_[P+!K?XY[1J@4^3>*9CM*.N-F$I)?4<#3=:C[H#6V:6TT;A MZ)V*=LF%V6U:5F>KB-+ EI1B1DZ-/_P[=*8WX/6OET>AD-[A<)EVC5_P#U2@ MNRV&GR3?W%$"(11O#XF25WGB4Z J!E2 SD:*"GP<<=J$#47Y]F:/!B X3&'M ME3M=2W:0P?"(IAUL0'[CG9(=V7)D$!D)]V*A'2(A<[-0G$#>5HGTE)NCC)$" MW5R W ?5Y^FPEN3NO3GTYDZ4Q^I9!U^ONUIXO12- MZ64&MU"C,U=4=1CQ"9DC47TX?0IK*U9^1>8+2BS,?=2/QW9IJQ!$3JS,1SN= MS[)3+.9V$_W*^)+]A=7?,U=,S_*3 M,D+2??LT,OSMBWY[#T;_5,@?J824DYK5/1(?K96,&8^A)VQ1 7.";\WF25+V M:QC,SG'^WH+4AQ%09]=#A^$A3(Z(YK4_'$"8!8E[G6( >PX_)%93@8W.%")D M-6/W+384'XK,-L>5IOK6-[=]R1O?J8BL[6,OR^D*2/@57\D-\Y1(A?:+8_5+ MCT$QBK3V^@^-@N5_Y#?]GL*PMY03(6>0E\/R5_PRK.[@I&?>^W[Q7-G<]96P M]2V/=>VU,7K@\K-X.9!I4?7J)5U)VN'6G5S29=UPK7JD?@O-7"R3DU^(+!ST MR_)GNRR(KLDHB*77T18:F,TK[,LKJ^AY-^>H'UUC<>JG?K"/1)9.N=M"0VH- M>Y6Q1$+\:<1H!D%6:X<9&]0MWF3QE.2Q7,INA+'@"0MV;GM6]Z=*9:'7/5U' M,E/TI7CN$-,9WV\Z_0817"3>T/Z3C%3(@SE?#;9GCPSCWBUY:8ZH"6!H M/M'*_.NJ<8.<,D%^?>?PPAM\6O2*[+(- --\L6@6J .H1 7]I%M!::&6BU&- M8L^(]E%WIG>Z+-[>FPL+O?K1;+[6AU<@LG&O69+SVNDNW@&ASX"+CO@[X582 M'S/>?UI7$WT]"B(<&>YT+R*MNNJQ4L5#E["0%TF/J, EY]VK8GO8VE7!>*1V MF(TR#T&P-P0L-2&RJV:OL\3GES0:FDLDGY#95M, M#V>0G%17I? ^^NU@'B;'+4\V1_!%K.'UA-0,>U(-%8@/0"*(>C1>72/98=." M+S;\[7RFH2>\S&VI9#\VG,<67R"A^:-4!"OM7.+SUP=?0DXGG2/:>8MQ@-61 M4^43).VC.\]%-0V>_E3_[X59E0R_2KNO$6_W@)WU$Z9[#WM(3K MF.QXK@OQM84*D$*0;PA6N,AN*G"V2]1GI93!9P8I,:[$.:[7?J["GT[E:RJ] MX3)/[OW37[77H/$^,.Q-V!R2^"6_4%>,+L-$S=!:0S[:<+/A=:!V<+CTPQ?^ M_G-6"\*$5LKI.81W# ^Y/.9"E%X>IOI#] 6S AM-L&7;QXYT[F5QZ^)CO-!N M+'M&>LFY"9(,+3+SA/N;WZ W+UN7-%4,!45&JO:QRZIWWFNZP@V/?5)7)$WBPD+F#I<2(;5S SY);/,GQ>'Q-)\J%-K?%! M,IH=3E"!UF91L4&$,$1MT&;25^O2O;1>P%]5->#K-JS&GJ9HT-;&4<"G^BWE$!YCNF A(=>%"@F^;*)=RK%#BL:5]I4(S9 L MZM46KI5M(2520(W/(QF]*@ZL2Z#]^^(23$YJA;3LSWB*G$\%/&1CN+; F@0S M! %JA+-)'S=1RJCP>3$B5D%_N2(Q>>2*Z]7Y[JNJH#B&%U>9MV;:Z^P)H093 M&@[K*G:V\X/!NBE5*?TI=NG,,K%AH /4$RJP7%':M/?\HVBD7<( 'B]P639Y M5\:J)0]MI.KWXWW_EI@[>=[-A=U(:-O)F] M!G/L)Z43^21EQ/79CW7IKO9,$]VL)R7MB#$X0<9C!UH9\T-,&:=&R';HF"#I M85[NEOR>M[BM] @=)&L O6_-'ZY@TJT;RZP#B+]98J694XEBHJA'V7VGB(>9 MKMZ;"HYVKG:(K)E,U?P\P/( ZIE S[67^BWC3)LZ7:\NL1^\ V?*4?RD.@1;'^T^" MM;R\@A[AO$IDFQU;3A(NSLL=[E<-2 =]W[_[=]084H+4(, ;HG1G+TSH7JLQ MKUGL#^/ERC.@[&L9P@)@]8>)JUSTGF*0"=A-'&>NW[NY%O]LQ/"3(\,SKN"M M:XCQMJ#4#T(*-F>Y/U6)_739_+5&,1<3<,N+#M2J4K*C<$V1TO<9'Y=RZBJ4 MR!'B,/7G[RXQXJO\_&2I@'/E[:4RC4.+7JX?BD:O@I<_^;4[UVPME0A8B\>R M(PL>'?ZFL!,45Q&)*+XNM;?;8D*?'.3U;OW\W=%R+8!WX+?2;T4A"7:^61!1 M(:Q4:0#C;<9B%[3?*5.)\%6/)#7$*&9TNXDG)!M9 M!TOQY HQ!%P5@U !AEU<3/8JUX]53-/FG?E6?$@IN2 4U/[[[%/;VF0A3 ;7 M&.R2V!-H%65"?-]/G!^^8S,-^9ME3ZK/6(;M.O]SQX&K?AN*G5D\Z$>>;LL> MR?PX+PGW"DOAY.@KSU;@K$WM<*EF2*6K5Q:B,?=6C&[8WF MXU;IS;;"V5LH0X-"M;.J_<.](CK])NNBD;$1XB0>)M<6++SON,HW\5]6:V,7F2DW\M6\*V2]Q4OM@ MH\&O@QNO^9RH ,U&'X+'RE(RA8M0N"B';?F Z9U2VC%'X/N>M* \[YKTY/#* M+C!ABB)2CH_N$NB(AO#NRS$Z/DX*!"AF*$.08'@P''^Q;D?<,C[R0O:P[:.R MC*,/JKXWOW8:&G'J7WK-3!F'84VOT&R"TT=9XLY:$^H6)9#?=RQS0J%IL8$<.#7JW\$'Q$?5'>I F;O?V[KSR??:LR8[77F6+!GC33)*C H FA ME KTE@%2QSK_+3R;"*+_;K29CVB=TL%HUH31_KW"?# MQE;GTWI/78Z8W:H"8O1(;%0@9VR;UO.)SL+_IJ]\DJ>PLA!A439(DX_E2A5GTJF3V9_J4,9IK;T7IX'9+=\U6Q<\2DKOM%^,JO.TY]I]O M[U[V5!S>7W0P/F\43)<.(HCF?&?RZ+,X-D_,)R<_]B-KS$-WI&-ND\P)L%5Y M!$%!NC3%&9O7J9S$U%RI,U,QZ>XC45L]+RFNK33,Q&@RQL S@X*^HWM"M;>MW_=AFU7$Q._/;>V:A'O:WF#0@)CAF M%(4UA3]9$D4R$Y0' @C;O9N:S=5]>E.:6?8?_1=6'^*4'LBP202OK:?[C,,Q M@W VR$8$+IE\2&M1^GW6X>P;I]&Q)N_6Y;L[ M_O&!Y\\[>)VV9A"XM^RJS>J#:*>Y.S%F%B[TVE?F,XP%TEC5!I,GZM_ZKO1' M*O%IM[-"G?.MH"&$V$EY<%&R,X83NO+HLCTH:+[V.V/4QI:K^[N MD_HRZYZX&?99MO)7X5C0C MB&!&2I1B?9BG8W66XBBBQMQGW5?K54MXBI9+X+JH%I<]0-8L;^RR?N>X$7-V MJODL&VCJSZ[BXN,FKYLQ(>-99?$J@\#J+QUML<-E)W7R&_#YC8XU-#P92;^- MO) T79GT>]=/JC75M+'ME!K>G?=BJL&%Y3!5?DE93_I-N?_.S=__1R'4N?\% M4$L#!!0 ( /:,5%O+ "G,0Q +F/ 4 9&AR+3(P,C4Q,#(Q7VQA M8BYX;6S%76F/VSBV_9Y?H:DW \P#FBF2HB@RZ&20J70/@DDG05O+WZ[^1FPB[^]>?'BQS\!\.^___HA>I>KQWNS+*.KPHC2 MZ.CKO+R+RCL3_2LO_IA_$='GA2BSO+@'X$W]V%7^\*V8W]Z5$88XV3;;?EJ\ M2A15%,($&(4S0%*L@$Q-"E*M#6$),3!E/]R^PI#%#*($8&,D($BF0%(H 4XI M3I51'$I3&UW,EW^\JOZ08F4B2V^YJO_Y^N*N+!]>75Y^_?KUY9,L%B_SXO82 M0QA?;EM?;)H_G;3_&M>M$>?\LOYTUW0U;VIHS:++?__RX5K=F7L!YLM5*9:J M EC-7ZWJ-S_D2I2UUWO[%;6VJ/X%MLU ]19 &,3HY=-*7[QY$45K=Q3YPOQJ MLJCZ^[=?W[="\LNJQ>72W%;?[6=3S'-]78JB_""D6=C>U];*;P_F]<5J?O^P M,-OW[@J3-9M=%,6!U:J7O.HEHE4O_Z<-[') ]T?J;WG:UQ$Z5]/].%8?NWSZ M<;3NWM@1PIR_PWLP@[N\_D']M-13_79W4(.[?OX>C_6SR$NQF.!G\0RSU^5% M]<8'^VH#4QGJ&$QKG,W0O==5\U2:I3;KT?+ =#37KR_LJYDV\]E/RW)>?OLP M7Y5V9ES="+DPLRR1FG&6@$0R!@@3"6 H18#C%"E)-2$\G96[G_3,+,%OUUOT M&J+3_H4'K[)%GX59Y8^%6L]L%K.:U=?=>+-&C+:0T>\UZ/__>/GU#_T M-GN7)U_!VV+;1U&H'H]M6ERJW,8>#R4X<%Y6Y/=.9,K;JIZDMS2LWFEZRZJ02I*QFBY.)JY/0 MOKZZ&_I+['#6LR&G>5^:^]6,IQGABJ= 9BJQ(DLY$%H*0*S [$>"")&$!8 [ MC*F#P HXJI&#(\%G__A&@T&L!T:$+H0'A(4GE$8(#9]M?J?P\(14>XAXVM13 M?G?%["UZB:_--(_+WDZ0%/2+^ M;D,\^GV-[3H4]7E ;Q:OZPEA$D\<($[B$?>QRI'F>L"RK>LA"=D\;#TL]3T^ MS=CD2&(W0+FV]QNE'E?@5HB'V=5"K%:?LNLR5W^\R^_%?#ECE)!,)P;(5$(; M&2@!&%':#E(),13&L?W897QJASCSR%0#1GD6U9#1[VM01TEV.*9[.!J'KM] MY,O466K]9!JB@DRL9$UG\_0Z-#"+:6 T5?>PFYA5OMS$("K1/C$T68;?1V ^M6]L$ MQ-3X)3J9!.DF3C*$"\H4!I)G!)#$IK2",ZLAICE%,-&48N>8N@/HS%*RR&TQ M-?6(*+L\Y1!3C\3?3VP6M#F"I"$Q=9<'/&+JD3P1%E,/\8A?3.U LRNF[GI\ MNIC:@<1!3.W2/F"4@@VA^O:7QR7BB*004)2D@"A#;8Q-$+!4#99QDG(EG4>I M#J SCU*P/?/W&:6Z/.4P2HW$WV^4@FUY;M HU>4!CU%J)$^$C5)#/.(W2CG0 M[!JENAZ?;I1R('$P2KFT]T\_WMKO65??]<\+<3M#*F&9X-0ZC6- H$T[)%4& M0$8Q%3;K3[7SJ9 #RV<>AW9846;!W)..0_;]&47>7W#V+Y;1;'E!&J8Z"Y MJ 2"4\ 3)H%&*9$Q(IHQMWF[&V>:G3.S@8YN:^QJO[H"]]T[:_94OYA&XN\G MK0WU+6JTAHVN>J@'[*)U$ANPD]9L=^+=M$YRISMJWH2L0Q *2@RFB0T97ZZ?#8^C1@SB^>]:';B!U?5A;$+DEH%->JB M61N# 9K:,S:QD$YIG*JGH4W >46C'HM*BD_JSGY+YJ.X-S/.D@RF:0*4-#$@ M2&$@!(9 ,A,+C0B$A#J?6&P .+-TMI"1V6!&2POJ<6RQR2?]$AK*U$]&.Y); MN.AC%TF_TXL=3,+.+S89G.X$8P>=@S.,7>V"5GI(M^I#.OM9#DI:U'N:UTM'A*Z?%GG$\X+O:0Y+F MQ0T6MMS3X02O]9YQG!&ZX#/ *;XK/OU$NY=\.IZ?[NK9?N_E4?"[R+W-+8:9CKC,E-( L3JM%H!0P2C.04HX@-!FR&:]?+-T, M-$U<+=;8/T2K"MTWM&YQD6N8/9QX4,C]=LNY!K:_BF@+/68$WDUN0#3>8GCB MR+R;WFF4WM-^H$@W?WV8+PV:<2B9X#P#L9$V;)=4 %&=(&7"OI&EB529\Q&1 M5I2)Y;EY$2VJ,\WY,E2I!W[RE&DH^V$:W;R(*MCH4P?Q<(DV$1NNSP.KWT>< M3<1:E=G8>#Q9XAF&J:&()@!I10%1V@#&B !6CQ!IBHE1>J@L\?>49?DU'RY+ M/$"67NQ'E.5-!_%19(G/(DO\_66)?62)0V6Y/L5Q$BG'<)-2*:C3&&<:<)$J M8/-P#H1*N54FQW%J,W0)N<>AL%:@,XO3(K<3IP5M M3#5C&'8HK-T#7H?"1O%$Z*&P<(_X'@KKI=E]**S]\2D/A?62.#H4UM_>/WBX MJL:]PHBK7)L98Q3B5$K J4U1FL;.5S#W#9]Y%+JJ P2+ M%2D+YAX0''#OCP%"&?F-*S69"B:ZZB+C-1?3/%6KLI"J'*&%4J)T0I@*5- 1)(!GM@96B&L(8]5@E+AK(5]R^<60X45 M_;Y%\[AX?,C?00^AK#P%X4K(3Q)-G0_3Q(&EZ4311.! %8T-_&6Q+5*XJ\OU M3I1FIJGDB<($9)A@0"230,2"@3A.C(R5#6&Q\U31B'!FF>Q*+S[4H)%9ZDA[ MK<^$]QHU^M3)VTN$_;2"E-AA M=C(Y]E/;UZ1#Z["KZ/4>2F5R_Z;MVZ?Y:F84YED<0T 448#0# &9<0$0-BE1 MDA.1QCXWTEN1SATV'EW7KB ]KZ6W.ZE;F:-2]XPMO5A[7U'O93323?5VG$DO MK/?2/;ZWWO] Z&[(E35:B,5[.P \_=-\FPF)F*&, \T2#@B4B9U"M0 PC94Q M/-%)YGE,_@AAFET0M0:-YA5J](?Q/AI_[)?^.7,P6S]%;HAN\*(:,/IG!]& MW8X6,@-V.HXM3KS+T4+H=(>CK>'@>\XYC!_EC8#2[QCY_4-O*<8S0]M3X M]PIP6VEVA+GMSX3.GC?BZ;VVEN?9IM[CYC*',;%.!(R!0I( 8K &G!H.#",H M22 A5#J57^I%FF8V+<63);^/'GC?I6 MSRRF#5:TJL'<173(OE\]P9S\9+.E<]U-QTLNC5T/TLFAIG9U'XYK@2TTIA%G,@55(=;4,42$D$R) 1(F&*2XT\:@BW(YU9,A5TR]DV M[E5"M\-7/8(:TP-^ JM0FP]S\; ZPAU.\"HD/(XS0BL)#W"*;RGA?J+=M80[ MGI^RF' _C:-JP@X/!)83MBESOJR7F#<_O$0PI'D5&R-9[=TD%(CJ.&Z::"A$ M1CA'3K=66A'.O6=3XT6K"O"'Z,_P)431@RBB+V+QZ!@HMSNG>V@:A;+?D+1A MN]FI&4UNO4S&JB9\8G_:8L)M]$YJ";RIYFQVV/A]5P0EC?S&JS :4Q-D1RF,7>M5RVQL^=+E<8U;D A/\J_S=:;=#] M"[GLG-&OUR$4/;/G0W;7?>R"*K@.DF(;RK=2[,[DVY_?,I$NI?$41[= MWW[@3?//N0UK%_\W?ZCC462HQ)DB()/4)M1IFME<6BL@-4UUG&&C,^?C'NTP MTT3ON[OF#S5V])_Y@^?-L@Y'N0;N0^D'Q>N[R^9KV,CBCAZC=Q$;?MG\T.SW MN6W>2*WUNGESZX'BK*[$?2IN\J_+F65"-*(,( @)("BVJ;;&&4@%U0+9U)OK ML.I)SQ@3RU)YA>)M?O$48AC;82JL[X+:";)"/8,$3RD-U]^>S>\COE-2K&!\ N]-_;162Q)*ID1@"*. ,'*1@-EQN>GB$G0M=[_C@V[CUH8FOX2[ MW_VFN[<'G[<)8=^C'^RK-R^V[]@_I%B9-R_^"U!+ P04 " #VC%1;^LZD M=*\) #]4 % &1H&ULU9Q9<]LX$L??\RFT MWM>%A?M(33+E=6:V7.N9I!)/S=2^J' T+%8DT472L?WMMTE;F_@,QZ*7G!R^EQ\\;,/*]_DLEH3 M\K9[VV%Y=E45I\MFQBE7VV;;5ZO7*NJH*54$(L]$&AY),&"(20FD51*HL?\X M?BJV'Q^W?X(OH89AK>INW_?["V; MYNSU?'YQ<;%_&:K5?EF=SCFE8KYMO7?3_/)>^PO1M6;.N7GWZO^:UL5##?%C MV?R/7XX_Q26L/2DV=>,WL350%Z_K[N)Q&7W3J?Y=OV:/MFC_(]MFI+U$&">" M[5_6:>_MJ]GL6HZJ7,%'R+/V]V\?CVZ93'[CEU#MQW(];U^?;[OX8)-^VC1% MVL@AJ;==>/\<*-Q3:4_T><<-G )L&UVEN?5F6\U6C5]G59;=^Y\@%6W=5% M@F)Q6.(->!#JIO*Q620!F1IJB921$NF2)1X\$*-]8%H*G[2X+6L;9(U1=FC4 M$/=/RR]S_.!YJW7[1R=Z)_@]<]=*/L_OK4@GV'8!21K@E!$=='M_WO[5VV^MO"3BHXJRL$E28S+;F?!7OT7#[-KII,3_S%7X0BNI9#]/@'J(H2 M[XST#L> 1>)>9,,< 2E1BD@YL=Y8(H+T0!UF;ND&Z?I;9GLQP*?/P/.U'!F& MZ\3X$4Z+5HE-\ZM?PR(+;8VDGC@+D;YKJZK!,L/#1<9SJ<0)>.]0F1F)IM(2E MP*B35AN@ X#QI!.].)%3YV0XG2>!S<_%"GX]7P>H%B;C4-?23AV3.!*VR$-F M)*0454Q!,),&8.2KQ5Y J*D#\4P%)]'[)_[R**%612ZNRZ&;0)@QWADK2(@< M,0:J"8Y\&0=#$8-SS#(# Z#PB/E>7.BI< 65C&C M4P8"[8J!9%X0*\"0#,Z)', Z.<1$XP'3O> P4X=C5TTG"@9?F.!Y\"J2R$$C MW5X2FW NG1G+.+/62/INA>BCIGN!8?]Z8/PY3:<$QB'^^;XZ*2\VBTQ9%,*Z M=I%,$:D=15$8)UHFEZD40EDY'!9?#?>"POU%H'BFGE-"HILPOZ\^5.678A-A M$:0T-%($VOFVS,+2VPG+"8Z%$J/@T=@!T\4=Z_W6L>A?A(Y=I)T2(A_*NO&K M_Q1G74%%@V4ZI4 $UPQS7\0 J/9$A,0T=9XFB,,!W3%$F2$"28YCWZ$P[?6^@$PX47.9TLWW MFW.K#\MRLRVL.:B4:>)$T58 X(GX8#4)+AK.@^,@V4[=?M=BOZZ?\*+F3A*. MW/V_5T73P.:P7*_/-S?%<[T C$!9;TC(PA/).2.6*\Q;/"BM- //_$X,/&BV M'P@37K7<7,]B-A\FN0SQ=R1 [.:W+J_=FB6UAO4]KARM?U^_RI*>/G@\NB7NC$A/-: M$Y\-)S)R15RD0))-*6HEHE)/U:'9UZ'S^L;2-1:P:NKME:]\?->9\0[E[MS% MY4OH/0%POO7_7;GVQ6;A)'72M#E/VXBWD<<4*!7>1E[F[+(#SY^J1)Y#S'TO MQD%EX.XM!]5Z"K1@?=6>*,0 ?H%NR99Z "R>/&EW<&06) M43TT+'>=&)>577OU+B0[23SFE&19+0[H/O\$FZ*L?BT;J-^= _:>OHG#<^4C M\XHPO%C7%._ ],PJ!"C@T$WV>/QF&D MP2B,)2RZ@+DT1 -OX'8[=@7 MJ7)6X;#GI4"RL\.2SN&<2T,,C@43;*\4\921<8[XO\R@,9"48S/!]^_%(>AV M]$O::94X,5*T)TUE()9Z1Y0%:3S/CB7?;]1XU,8XA_M?9M081LBQ@:#[YGX@ M[":0%!5D206Q3F(@.C/BVUERSLIS;K((=[]8_%B2>-S(.$?Z7R9)#"3EV$RP M?7$_$'<32/#M(>/H">/M=R-1*A*\ED1KT%PJZG2F_:82CQL9YS3_R\PE!I)R M?";LW3CD-@X=)'?)H?<0D.V %;4/E!,5K>0JJ78;J!\2C]H8YRC_RQ QC)"3 MVB,Y+C9PU,"Z7BC%/ @*A#D<\:0Q$BLFRXECPH4DN(-!SO3?,SS>(PF&6@$? M2M6Q3^Q!/*\P",;#2=&@%A8+Y6!4MYY"B43"23"4$J^T5U%(*7?<0[]K<2J; M(<_LOG(@+4?FX*3R[9.L/EVM0[E:4!:=: ^::N[1<1TE"0Q#$(YJ%D-6.N]V M3N^6N:DD@]T)>+Z*$TD#/UW&I=^<0O=<#2I]%)IC842=)](F+(R MF< # ^> M.^;Y;A0\9'6\)Y2\5#IXMJ:3?(01:)N%T(H(P8'(B!-@JTTF42@>:880TC!/ MK_KSCS!ZD9/]0U.QNZJ#8?'#_)Z:&-_GMZ]N7FA_M$_+>_OJOU!+ P04 M" #VC%1;_J]P-UPX ".^P( %@ &1H#DY,2YH=&WM M?6ES&DFVZ/?W*_+9/3U27*#905:/(VA)[M:]MN21U,\QGVXD50GDN*BB:Q%F M?OT[YV36PB8!0E"@[)F0I:JL7,Z^9.;Y=1 .G8^_#@2W/_Z?7_]OL<@N/2L: M"C=DEB]X*&P6!=+MLV^V"+ZS8E&WNO!&$U_V!R&KEJL-]LWSO\M'KMZ',G3$ MQ[B?7W]1?__Z"PWR:]>S)Q]_M>4CD_8_WDG1J#8YKXERM]6N]QJU;KUMU1K- MLV83GI6;K?^MO(-/H;GZ)@@GCOC'NZ%TBP.!XW\X:Y9:C5%X/I9V./A0*9?_ M]FZJ:2A^A$7NR+[[@28,;WL>+$^_MCS'\S^\+]-_Y_BFV.-#Z4P^_+WC2^[\ MO1!P-R@&PI<]]3J0_Q$?SDHX)OT]5O-HP>>.=$4\KTH59W+U8R"[,F1G9Z7* MK[]@^\QJ/OXJAWW&G? ?[^R![WA]K_3O4?\="WQK]HF:K.ZZU1S].!]ROP]0 MZ'IAZ T_X&P>A1]*BSMZM;1P]3H&3KT\^K$(G/N%T;7K>H\\E)[+>,C"@6#! M2 #A>3WFR)Z8!MM3<_]W%(2R-]&S!U+S/\[!_-G/7KCH2GVE-5]REP^$S^[$ MR//#@#T,I&^S?T;<#^$I\=2=""('7BU=@J: T!LA^E\+9_6%\__6N?_C^N;W MA]L;=EFZ*!78K15Z7>'__+[2+)]7*P6U!I0G>J47G@]+56@^N?G7_=7/[QOM M&F7!M>'LO1J$8IA-IJHF45H)BZ_6@N)@*_D=,GL#\*E-&:AMQVP81771$ M+_Q0:\(3(FX) ''##\5*>]?$0;AKGL?SW]G(TY"HU$M-6OJ-")G@O@MO C86 MOF _G97;#$9U@!@+# CIITJIVF(C0( MG0BUGN4-AT"IP8!#>^[:S/7(T*#P:13>B4?A1B)@TD6S) "HUTN- MO[$)P+WH@>(KXF\@*]A/S5*%=15JI_%F>8 (7W64Z:=6*L_V8Q"U,:)N@?Y! MQH/!:/%@P'J.-V9C'B #M!:CI><+,=^X'CTN.R/*'<4<2T.GY MDX1QP$*[$", A@W3YEV'' 1D//'#(J,M\N.VA50JXB@ICL6/D;!",@6"DE;T MN43S%U\C.(5K%G>^& (= (!#X0;"F8!-8D4H4P IMG 33["^I$[ #BT5Q X MT (L6[P&!$.UH:A%(@[#P+BP.<(SV5P#DV^N1#3L&C@7$^,+MPPM% M=8X'(@*(:XC3&0EP!9$?1EX@PU@2#(0S0@(*/ =>!0 ;M/S1M!M[OF-K( 1 MT$$(.A=9";@!/@/':6 A_U@#[C@PJEB+FG9N[7V* #[_0CU%5MYM%#J>]WU% M*V^WA/\ T->&.+,]T+NN%P*Y Q=8TA'L)A'>H%.!KY7!!)@(N .-^[XW!EF$ MR%W36 (R ,1+$GDH(X!8"D0YW$=9@Q0;1-!NY MX!-T!.W +AK:!\(42@7^6 M[DNL+T ^ U5,\#7Z!#:UBUQBHA'P)0@YG.L)K@,\$!1?HY"X%#EM2 *0#X&P MY7^4TP)$R:V_(JE(M^@+A]H ]W.W+W%VP,\"^ :3JF[V%,A$P7<%)S!I;#( M36&UV%5":&&K='0)R[9"[ [!#)XJR X?N,N:H( A4!?8>""M03)$#TELDI"8 M##+= 6QCJT?C"91-!:P?$D31$*>%?22# $A GO1!SJ&(0E #IP-2H#E.*G&U M6.QEG8)@L#A(0.H'[0.$%,H?1Z R CTQ /TQ]B('E0X@N>= ?QJ-0&I!!&LA MPM*(!OS0,QY0ERE$EDT2U:'O]63( ?H@RPI9G &X@+\$T:,6> QIGYX' )H0 M9LY_:**E&1=H3.GK/[1D!%0Y'HI#'$_)9K6^&(E>%%I:D#FBSTF^HGI$JC\E MG9\*,L +D+,M+64[Q A3[.-C'Z!>0)^,!!F9.&0O"I$+4,W&0!V"DPP@11_9 M#U$KD;H)T2C!62B%X(:^YX (?YB"I9+BB]!EQ9C"":%8POU3P"<:58I$-IBD0=\@YH=X4@Z%\,-2?,U15H_D@HH/I$I"H=6 MJ54F7Z55:I<)'9(\&R>R!=)0UD!2V%WLQ)#"16$+U#@NHEWG(&'U<;XSGM%B M 9'3L,B%Y_8$LC=@!&0X<<(WT45%PZY=6,J00)-+S1F'NP@W*%4BL*$D<>D" MDYZ6UI,NFFW 70FM).@"9@-6BK^BUC-TJ^@&R12$)!^-'&F1JOPN)DJNCTCT M*9[4:A7[!FGG@=R+_)C"E1SS2$[$X+<0_"H"!ZZ+3\H3R+%-L;MRF?'2L,2N M'K1(L6)D<24-B)GPD\!!,012+@"QHLB:X-/%\(C"*U%Z$@2\UG,)M#W' C0& ME!+6$$[L0N@!Q#O8">/QN&2KER48O #"$"QI%5".NIA]P+GH$:Z4[/SY?:U] M3MY;/+/$AF2L _ :.;#VV![5CM+VHKNE6(7CA,;21[%.8A+@1\F7J25 MNAI>*J-O%OTI2F86?9*1>->726#\GS6PJ4KS=#C[^3P]KD)@";5:88$)PL%854#O.UX7]!&FWUA@220UI:L \7T7''%I!7'HP?/)11O*4'L9 M2"Y.' 8D4>:-80! O.Y*HD)><4 E#2(,T8C39$YA ^@>&(*[<=@@$S+0AC"YA3!E9<;[ MX"G::0P"(V\*3'^'E_8CITS4DM44Z0$M!UA'N2'*^2)P"6A (0\5/F,]=)\! MA$.40 "Z"!V9&,X:ZM0>?(3(4D(*/ 0UK(6+<\&Q4) / !2@'J#?"=D>:/^! MC@=ST?%&"G\J+$68+9+GI)'D\Y&D\,ZG-(9%"PPE^"D4W4. 6:*0"3GI.5!H MS(N"&(OH/!3(3P![Q/=^D#\#4VK6"F64K$G82T%WC))9@X2\>Y*I&;I4W>)$ M0;T1.'5JF*2L=K/))QT)#[QZ9;&0;XRR4(0))?80KVKJ^"G7Y" 3!*00Q%[@ M$5C7 )2K'R,'7RLDA;.FQG+UJEFM7E6;%.+ UP>*'@ FEFY;T'G]#!1@0_FX%2651HCX%R&J[/>K)]H2!G^9<^J)(0<\BZ;,/W!GS2?!N MV8Z0&-BS<%JZ+2!7&N/F]D:Y>E^N.O=_WEW=L\[-);O_\^O7SU=?KFX>.I_9 ME\[#U=UUY_-]+JVZ:S>))>AX7L;#2>(Z3T7PB1R* MQ*19I+D1@&O!>;0B1UD):: C;E! -]L!)D[>CP=J_TFF$1H\RMA(8CL802.' M:@ *:#86GED?2"R0:R!+,;Z>-91(%VCKJ R*(ZKRB3..-.7AJ(.@$-S-.TR M4=&IB!F*/4PYIZZ@"OI[(4G3S#R4#$+)Z.D1$W F0W-*/E!DPDZ\G BZ)B'/ MG=G)!]8 U!3&0L.0X^_Y]#PR-*H4U3\3OTGMR$'U]PD@Q2KEXC\3=WS:AP=$ MQ:&C!92J(DH+/-\ISU@1E(HD3WELA109TR!6%@''B+R(&0%[L@7\YA =PW2 MMG KF/;&DY1>(0X=IOP"C@R1!'+?@#\B08/= EI'6W,OM.E/9E3EZ4H$<;;S MW,SMW;?.W67Q\^WM_US?_,[N'T#&HKC-IXR]QSRRBM$24\I40)+QA&R+*9L@ M!#) :9&21#9B1!2:=N6+/O>3%YF-6(31;&8X)9_9[5@K1*QF2>7I'"%,IZ#) M>**%V,(IZV X3$/;N]F,0RJFT>I+%J(\9WB$T7,/;>]8QFDV03B"RUD'E/AC M&*B(&3L8C9YEYY$)1^BL:NQ_], X]P%0P"N1#RL"H>KP<:!"9GH(X.:(?&_X M)G55>N"6>+Y>@@K%J^P*/(]2T!>F%TP)_3B[;PM+!B0T@),QY2#\)):/^6K? M&T+W'F:$HGY?948\!((-I!*J\ LE8&;6GUTZ#H@!D&! 4T2R [5JD3L?D723 M)%R\3(YG>7<*+H%(5J^U3P&3<0A5H@ $=C]0@9+IQ%#(@:-Z:E:Q8.66$IS0 M2NDMM; T&)2H1\H0^A*UZ'2WJ"-LT87?NV!@QR:#RG&K6% BFAWY5R1MRCV! M3 90Q[L>L1N$;1 GIV)BT]XVBGEO.%%#@W3YCLG$,3HP_J-(S(^,I:.:%-*D M#U'7=*!7"? ,A>"LP)F9J-\I_A-06@+#N^#J8<^XHP&R.$9T] MFP.37DGL9/LR$'/SRYH=ROC"2 .P!$)GY('10O!/I=3L.Y4Q _6'8_KXZQ!U MH>T-,7=FT>QA_8HT?WY?;YTCT]NVC[-/4JFQJ$$+@#)C,95 8YW 5BE%\G$G M%AI3L>\YBYS"='?D^::.?];_!NK'6!J*Q(GN!OSW<0+0Z6""U,.#H8K_P,(\ M:IU@7D570O32 8@H@\E75DDHEQ*<>D>1&"+2!6TUZ<>2,L&I#JP$A7CGR$@S M+1%3)JM N%"\U4],ZY,45W[DS*#8Z_6*#@?QJV=-*82$X;+=9+\:8D(4E@2P MDW'L"1>;V?4!0@J<=7]R6M!6E%)$<;(3E";U$**LTU0K?$SR*WF(PM?KS2%+ MI;A! 6'T5-,,15DH_))RN987E'L.8D9>,+NY :8H@+:,R=XD#J0$T5#E?C%N M,O(E_9Y)8"L:"I$P^T3I2>IY;ASD@C[%DG!FF2#:6'>I][6"E1[[+U,J7O% M@043((R$$M6RN\(5/:F K?+S4TEV%1%"*@-AJ*8T_3W(A>_3^)[N8&I=Z7+5 M!]!B($=Q.)+V185JJT#&L.$_D@T:6>F^<%[9>8PPOZ.,%C( KK_>XA2 _L.B MAWH%N"88@=F'?P#E::T^H4U9X.]0 S6:+0,_&B7.I1=->U^9B&$P <4[I$\? MI9=Q6&T>(K6$HLX'TE29/*XV<4F1J*<,32!."PN@GXJ0=+<# MB7//L\E$RCJ0,]M="LOV8A347@I B!9K&6:A/8[PUH\W.@#J<+\$/LN@IC#% M8/B.Q$\JCE!2 -?+1(\HUXH^Q2[Z>F><%C.XD3&S$^-YTD@I2JE$H2PO)6)# MQ;;"?92^YRI_N!#K/F)4WA,ABGG<7JEQ1^=KXF@$^].52*)DS@< [D?A4T=S M2AP!%N_1 [Q:'"@@MB#D4%"'"1# QO'[:I^0/]?3PH60EES4O]9=R3&PS!1[ M$6UE6DA/JJ<":4=ID=4=>+UP3$DR@1(6P)%NP8E)5"D6='^#1=TB$,!1C= T M5-2>FEZSG 'RGR2I(J""WH;C^5E2R 98$ED_]5V&0I+(<,Q-(\R!T/MI)HM[ MR@SD"Y*WPUCO0D_?]4;/JUILXHI39>;R+E*7H/1#LKLUBQ EG+(B6UD36I5G P^QTH:E MNF II.;(>Q]X67^(E(N9*PTX#./[/8IWR]VH$ZF_?T4",)1X9M@2C[&$A=6F@(? MS)@,YP>#*+2]L39'AKA\CE]Z;@\$]NF Z#9>,>4 MNXT!@47.]I-^-+FMRQUES+!F=XS@[.^O+L"CPTT#4RX/OJJ6JW76<5T$+5-'>_F,06GP[] GVL*)SK*1F.GW3-1)>2FTA5:[G.('VA2QZ".' M>]J/F-YRE^PRICU+0D5[$E\;.XU&:F0Z7R #U63IY"D,3D2'VZ(T^DA+@O^4 M(8+"S&9*E23-Q%-B>VX,0^8S=GEQ>_/0N7C(9:#RO[V!RQY*[#=A \CM OM_ M: XDIV4*+(XI P$[?,K\]_Q2HCU^?M^LGV>BR N.4N]ART3F2&N!5:OE,OLJ M7#>8.(]@@G+6T:=@;DK?2@5V'V$XO%TN?RNP;SS %:(W^'Q66#(]W'ZO;2'VW\I;Z M;L2G&W_?U]J[S<'U[H]/AO]U?7UYW[JZOEB=H]CQW$,OW MMY^O+SL/5Y>P@)O+JYM[^"W-++';3^RJQ?U<#(5*M+'U=+BU_]U2WE5JIV6YMU.W3[QJUJIGL M*TRV6FJT#X8,<++-E;[\A?A!\01P70#NQS_>U9([=C1[?ZB.?K#*-&NC$)AE M/,5SVY%CK>?-C;(Z\X]WFR0B3"\X6+H*3U=BU:GJ+9A*;@-7-HLGM9! MX'[^..VVEKV4.XX4?"T"7WT;\N-((60(;)\$]HQ8[G+K>Y\.H!3UDBQ+B%[O M*3"]MKQ>(1"B@(3W"LS"Y;EUK4P;99;CI?_T>LL^G[V?,0_K;1;*C=IB_;RU ME>/;-2'PE QZCK%FY9@AW&,DW$:A==8VA&L(]] (M](JM&IE0[F&<@^0RM7*P>+EB.-DO]/5NNJFRHUT MZG/&T0%1::W0J&X[D)0;P_!-XK->KAA\'@T^*^5"H[%MY\T@=*\(K56:QXK0 M(W;%,\4UP"E7UQ^LDL/=V!HV?1Q7'UNRJ)5TJY:JC7SRR;VZJ+405P'0E0B& MTI5TF!Q/B>&Q2S?8,**U "SY%ODGE<+9V1J>X!-X/P E?4!XJ1;*S34BC08O M.\)+LU MGQF\Y XOC4*KUCQ8O&S)-LV[_KT3@>"^-9@]3/LRI7MXX==:JWVP MP=4WB,^SQK;W21ML[C,O6VD;?!X3/NNUH\7G$6?Q;CS7 M2PP'?>_IB8Z,G)J<&+"2?NO:5!P=Y;OI$L]K4N(Q1GK=](TKII#MCE M#REM@Y3\(:5:,0GK/&+E<'GEC<1R$LVJPCEO(WZSX1''O+@^1XN7#1/6!B^O M'5H[\%C!\2*F?."B[(ASBU=Q"?FNP$*WF;**+]MT?0SY\DJAW%KWU.M:RS\@ M>_X8\'G66E=#&&SF%YO50KNY[MV&!I_YQ6>M4*NM>PO(P>#SB/_:DTESCF%;.;-DCQDK#G+_-'U;J]34.SQFL[ @KCJZ*R\[I&4@W'Z#+4>';6V*X9:#;4>"K56 M"_6UDZ*&7@V][C&D7UDW57PP]&I\IKVW-"C8>TN#@KVW-"C8>TN#@KVW-"C8 M>TN#@KVW-"C8>\LCWAHR%<@?"1_6-QQZ+@L&W!>;7UPS?R=1#?PZVXNZCI@K M]+G1]2FK)H7-+-_"+-_(\>7?>""MEQR$.ZY 6O[#9952=<-L1%YB8H; L/[\,^:&P++,X%5#O^:4$-@^24P,/D.3X(9 MP]NPUB&P5GO=8^F&M7+"6D=\J*8#<^!]D:3@0L_Z3N4V]0/Q5R0?N8-%-RD] M%S O"H,06L#"3)$)TX=QWE?-F27K/:HSPZU*N71X-N/;.,_=JM9*AV=TO!'< M5.JEAL%-/G%3 VO]L''S1C:G+(F2KT26JV:C\D.6E=K:JC9GR9OCQ4WUK+3N M#< &-[OBFU;IS. FG[BIETL;7N^7%]R0JOTEY%U'Q%&CI7$P!(I^@O&H.ORI M^RRB2OU0)[#%CWP%N-*,\K4$WGNOGDC7AK\^%,]V&6"K;B7 MH7)ME>8Z;N/ M[,D-YXP/ =-AP'J>S\*!8+ @\9E!CK((A'C@@QLCB:,*_'+KG+!\+_^7V[6FF=!^P3 M=,(_64^ZW+5@GK >'HJA0&S &/R12P?9"GHE4%] G]R=)%V,11>(4+"3 M\7A99LPG/RLW6_U;*[^*/ M!GX\\1'OBV+7%_Q[D?=@71^X,^:38"8! 2LY]-"D; NE#[^VD6YN@2/.X-M M:R%L+SLWG3^N[MC%[=W7V[O.P_7M35ZG>G=U<7MS4PNH!,ZFE0"N M2?8F0$=D=:0BBL[!P(P=/@K$A_B7\_A\F71I O31^;S6F5':-*!ZG3)OJ:P8 M6(<6],CZ=8E>S=AOZEVM56K6JTM?@Q&X]-U3W8)'W&PV-^KVZ7>-VO)!S63S M.-G6:MT^$QA[UOLZFVNZP+W2%OHK^E>MY^5+6=EN:,-^(?/TJS)/KT"0+H^8 M'2\H;O#),Y!X*75D?,AE-P^5YR\?RB>\[L4(C/$NZ,AJL\"JY6ICE53_*LM^ M:^!K$?CJV^"Y(X60(;"M$]A17""P>.6KV?\GZ-NL?9WY05T.N!@\:^^>/(S+ M 1SD,DLD(3&T5J&SM3,W*9T6&'DSQ/RH'[/48M_Z*I$J&%BE_ M"BZ9=$/N]B5F)7@0B##8(M6\\MF?SN)#=<>Y[Z9<:A[XMILC1DW#[/+,)VHJ MI4UK11O4O#IJFNL>I]@B:G8=;,V/4?")2Y\]X M<4NZCR((:5/7X=@"O[W %CBXXR[E4OGPKQ4Y3M2CL"\.C#;Z>)MQ5$JYMA?7E%36_?R X.: M7:&FU32HR2EJ]LDU;S>.\CN7+H9+.!OYGAU9(<,V#.TAK88/QP*X?$O1$SJ- M6#TW[J#!CL'.P3CK!BUY9IJWZ_%W%NVI",7P@/S_J[?D_V_&*L:9,=@QV#'8 MR3-VP#3;8Z4@DTS93S(E?Q,^E)9O-W3UP'\P6(FP0MP5C!DNQ*]Q>TC#^=Q[18G;]Y!$M#8.6/**EULKCCI\C#E-=RL#R\7;'$'3_ M0>KYWTV4RGC:!CL&.Z^P.]Z@9G?IP^;JFM^$I_+?#'8.%#MF?TPNT;)WICF*@K2+;YI9[\9V=G+CN<7U+GK4L-"W MQ.C[S\%48+87X;TE=%/,F[J@:)L0R>7U1952^RS_UQ=M$0U[=C<-[QG>R]R9 M4C&\=R"\9]CO94#))0*[S=>*$(L-3DG; \UY*.3*[HI/)N\";VDMFG MI-;B%\&#R!?!/"CTK&?JCTWO.*B7ZC&,XQ*DZMEVEO[*54@[N^7$:LJ)\S\W MNE45GM!&RY[G.-X8T,(&,@@]'U>;U"H]^0F;P0HL*Z [AH$57_0<8:G!U9[.[#SI;#*>2U);/4]_?M]HGV]&236$ M'U#-;DO9G;5*M68;JX*M7*C<;KU%OK?$*]=;,9%]SLNV5 MNC65[$PE.U/)SA0:VW>A,4-@AL!,);O-W/.O9(AOK^O0(J>8L M+5YOO;;N>=IUU[WGS1Z&;(^2;->^X-*0K2';O:^W4J@VSPSA&L(]0,*MYM50 M.(I]ATLNWNJ%"+IY8_PXC\[4&NL*1W.H:4>8J9O";/G$3*50;NSQ2B2#FZ=Q M4V[O^;JJI3L6CCB3_EN.,NDW"^N/8>[ZPAL"R4_^'C#Q5R3#">.NS1PYE)C? M'G$_=(4?#.0H6ZR,^<)">\K>0ZZ]MT91-96+SZ3AV0MV=.PC#U]N-3?,P[?. M7B4/7ZELEM=]+EM<,Y,]K,G631[>Y.%-'MZD27,'/I.'-P1F\O F#V\"[!N$ M"M:M$_Y6TD)OD60/@%Y/*N7:VG> Y..4G*'4-T6IE?JV,^Z&6@VUOII<7?_2 MX!T<>S39]6/(1ID;0_.)F)-V=2_WA1JD/,4M%9-5SR=F3L[V=[ON6\RF7RQ+ M;>\ARWX]'''I8XJ960, N<",N#J.'GHL%-; A0GT52[="P?"7WY,_3?I93X( M1)^ZS2;8@0 &U#3$]!+UZ>*4AI1=B;/L M,K+ E3*MC$H5YV\E.[&:?@D[0[ MSGKD^4ER70;IX?4"^ZG13K[@L8UR6F"0F?94^P>TL*UQ*+%X&MYF;][*3KM>JZLZY5ET&^Q_$*BW"R.O%L M-ND-(%U9,&5"]&; WHABDM@\+*%:70SW+&AFU] \6["(TEN\!>0R1WN7?N> M+$0)X-&S(RM42,-M-GIQFQ/ZV;ITWC(4HDL9YT@?7X#J085J1;X/>.MY_NQ6 ML;0.#VIHW"+FAIX_F5+;>)%+>L$,WC?3Z5I\R$:.E73Y+(5-B:#UI>A" ;1\ MUYJ&0ITN>IK#H]ZN0^9J]BN]":VL+_KU(P/O G3&?!-,+&0([ZJY;2-_K+GC)%5F[!M/BVZXN.S>=/Z[N MV,7MW=?;N\[#]>U-7J=Z=W5Q>W-Q_?F:9LEN/ZG[N!YNVZ M=!>=JO\*^ 4@XAQP1K&HUSNAL3?!K0&U>I1VQ)VL L,188Q+[G+T+ 6X74-. MU]P-9M=$O2+&"CJ+C37_OE]O76N]2A^^._(EP& (;;@Q@-I#=(O!J L MNT*XJ("L75B(HBL2G.4D1N7 Y"2V>DJDU MX&X?I=.R"I69H@ M >6+'Q;I#!AOFO2#T+.^%U&Z8/Y@.!)NH%9$\TV1H&:UB(1V2^=Z32F=S\$S M61^2=KWQ-&FO#9?"JQ/,+*^D9@@QJ039**@+NAPC6YBL]>L_!C&*_^]X80'ER*2Q\?(JT?J_#I(B( M"Y!H[-FFJ]@A,_=!(PO(WF3GA]W R^5E1>^]FFW=JGR:NW5#D^9R>9FLF>K=KL@7_ZJ13^?S[E79@]A:*Y\>I-6/@]A_(U=*"MI MV4$[-G_*A3V"*4"'G'T2:&1ZJ&]V?1AM*R=FGN^DTEBCEUSC6ZNQX)40=1 P M>/!"[L2G]'=TJ.TPJ&,J^?V2PVS;YNE')ZZV^'Z_[:*''K-ZLHO M.)V2&R">EYSF*LTI9 6EJCF%G(O(^T''UEOF#*FA MH+WE!0WUO'7JJ9@3R$=O=9I3S::/0^OC"-CN $]*=])J/@$5'[#-T>FW>Q#. M'(LT%&$H8ELNEZ&$(Z0$\#?4=RGU2AO(,Y1FMFPOJ MRZF)/7=>\LD2L+HWO?@Z0F>^LGERNA%/B66^T@103C_A74!W%"[_9&Y+^L[P M2B7/&],0R/Y75WR^X'W!5JG>;!W*L66<[&I%A=_8,<9G2OS" M_-FEL-1QX%IEO>/ ;PR"_Q+4K5Y_E^- MU_5+G^K#[N+_5@#C5.\[VCB^#Y2L??IV@[7FAOZ*G[TQ?.'V00K9LB_#O>V5 MUW2X'6H['#FXWKGE35::&UK[!'[_OL7<6Q-F"]*(SR_4.<\(;!7KV[RU;+P+1WG$$8G4Z.0A/.^M@(YW. M.=EOQ9-.8IJVCFFZ(F0BCFF. "*6BFD&&--<3_^O3C-'ZI__U"JURJS(X-]V M>9ZBUA*<.8F7WT>CD2,P),X=]LGSQ]RWP0WTOB,G7;L]SQ_2-_N<_[N/)S\Q MZ3+HS\$#I*<+)G.DZN8UE(BQ=-Y>+']Y"/]Y;6GHY0@GO'4;Y_54PC.7>C!K MR6DU-'(PUA$3\Q8FURQ56BO,;L'V%K1XBK52K3JO7KH\$$H9_S&36W]S!I9. M@%1+*Z5 Z?X@\GCW/5ZPD+B8N%_ =9 M.V_C9+XB'W!UR[/K71.I\[O"\X+:'=D]JQ2\J>$^;06W(H('G,UJ3!C2M<&W M_5"D1]N!4(-Z?Q)"U>4"MEIJ/VE9JT,(\S^WJ"+:*^T.7]UO83W/9^% P+^1 M#W[[7Q'W0RR]@7O&9,#P_K0AQQAOZ#'I6KZ Y>I/NQ.&1G2!\2"(ANCG8T?+ M1I0N$R12H#G.+"GSH6 4U_HH+!VMA<8..!M 8@#-Q !B&A,W*YXW@6D8J5C&9Y M^!KW07O4@?K;]4+U+7B1T'P$)(==#+G+^Q0FIO/OK7,@OT?N1!0;Q@8P9\_7 M05B]Q3HS;^%3(-FUQ/'3T'_OG(:6R;:%-C%*#EOTH!,;N5W.M*$F@,_D.0@6 M;RA*C#T,X$L&T;%5GP(1H:2XMYP*'P+< C,@ODUZ#D(.057YXG]R53Z:B>#:I5WJ(K;B#83Z,O_,]#6=GI5:YM>FYCM:K')5H M5#<]N_'4NUI[LR)WSTZVMK>$V%MNJ3WON$G,CBJ3MF&^[>P8\FUBE4,P^<-G M3FAD%[LJ#[7@U7QAQBWLYWUA";'C!W6+0%TW3'U,^^J>K.D8V[2;5Y)8.4^[ M$8MMXW#$-F>8/QH]E):;IB\VDJYYB7[C 7P+>6SD>X\2*PYW)YDX$L>DAPPE M>/^+BP6^.-61%T#\]**5Y3)Y4RDTF]6]7)NYS9,ZAL+R3&&-2BUO%)8_S7(H M+8_"FGRJ#BYINBB@H#C\GPHBO4C+K5KE(B]@6%T&+5I9+F702:U2W74%EVUZ M"(:V&O: LW6DRYW+>._';AU?5(MM-J571?!,+[; M&Z&N=GWG!59RH F.K^62Q%Y]K<3>%L/8!]A'_I!Z*"V/PK!:G(":WE/U%BN9 MYX_<#J7EII$TDTLRD9!<6HN;Y)),K,U0V.OFDDS$+;;W7IBX#SX+.7B=Y5K;@4B^91MA5JKO-F.T3W5 M)]UE/MQPPEOBA&JU>2RR@M#^Z:6]/2$(!I:0C M#0$8%H: C M#0&8 MEH8 3$M# *:E(0#3TA" :6D(P+0T!&!:&@(P+0T!F):& $S+E0E@E5I!9]LJ MS;%:Q8MO0M>P8+WI;5]8"B(YXI<\#@K,$4&PQ@$)K&*0V:"+.U2KY?-%IR3H M5>7\%#Z,5+V69;N L>-",M(S0R V:"MPW'^)L95J%\Q5;:K3#I#XD:^@6EI8 MXF"ZX$J*TR7U*O3@&C-U&F:N9$I2,!O0EOU*;QY3%>H;O5N3?1$\0+9:L4S';BG@BEN# MN$Z,&\]XJ&?, A&B8 D'C'>]1\&"@1@J\M0#1N. M190<;BG8H(B"_P<1%:3QJ3&5P_&&(^Y3(9+L\*JG(9]0;]VI=B#? @E0X+XS M8:$,'9A',FM5N$F?CM:%H.!+5XJ@I/:#L2])\2?HV)'B4:"@XU1 )Q!I5_J@ M-5[\U(L<6"H5?=)+U1<<>CX5)_-Z/5@6'L/6P "1AR2/T'V48HRO+F%8G$]< M( M:)<6G8G&IVV@AR71%+/WR@A8R220TS#%R0C5WK),E7'@$N+&DHXJH*?CZ MT&[DJ>KHTR >"&?$O,A/US)]#\,3M-J>%:B-/ M0Z):*S7;N/2Q!-Y!X&-1)T!'Q_YW%"!I7DK4"S;#(_U7W'?ATP#+:@!I#(= M7?<#CN@A&4.UEPB3C@/A""B.#-$\4I$ ?RIBQP60.4"C&1OHC#O M3)!C^[XWAB\TDD',?7^2$>^?+C[%YD(L MXJ=D0$8WD,[(L')?N$(50<2><4RL!P>($#YJHN3&0J"Q "FI'Z*RD* [NMPA M,@D&0H 248J [N_%EUDR0T*CQ,BB[. $=JM2QQ![90M1Q#_AV+UL&:N651S3J$8$8S$FAL MT06L"_]16E@2#Z;G"^4II=-#@P>\$LL7I*_]R90;I.P/;<6@FJ5QD#W]>2=- M%<^3:H:NL XW >Z8AQ+])'-@N;/\M%.EY>1? VG=%5>RAA*8 ,%2^Q$7X#M M(X"(;&TH G+TRX7(R=Q9@P))T2:6&TREEH(^C9G*1VU;SIFIRA1<7\&R6+%F M&"^NAS@[9_%#6!%5J$9I*]Q T2SHU+[/A_G$'M:IQ-*6.'O+B?#&(/+@5[/V M!QQ^= 6(B?3KI'ZO V2/",02O<#TQFKHD;C. "(;1]1CG(['*/H1KO>%6.T1!3\ M5?E?\B3!^;&/QJ&HGD_4& MJP7*Q'K:.A"4QDX 4%-N+GQ -#Z//X!$Z,LNB$ * )%%H.W>&#MJO)DOIP$= M8Q_]7QZ$,Z0O'0=#*!01F765@!:ELVQRJ;;L10Z"6XTI[-)*06XCC%<3QG= M-7YD 5Z0[B^4')P7P*KTNW2IU+:-V3AANQ$*E$1Q))3"=;4T]%R%8D1NW05>Z;^1P%=BK$ ,N/*G,9R MY F'][ IU@8O)+*>)G::&F[ N1Y-V/?L*!:SP%P^,+_R<&@1VF=1XG,(,A"W^8%8&+ :IT($QT'-H2N7H\R!+V:=X!@>F2R91CXHESY\Y&H&+F#? M&0T=Q&2"3GDB=>&CY6+W&:EK6'V;K'Y+3KHR?HFP8S:?,8^)LJCM(E]GW9#K M'(VH3C-VV80($XV2#+/__+[>.L?L!JQ:4;YGH18A=;J4Q:D)JD/M1JDO,>?1 M14,DHZHTU?\=M>!P*/Q9?YG9BD,I7:O*,V=FE6&JC(*EA>%@7C>P(C)]DJ!C M&N)184>5B_DN9FV03$@Z.QF0E]("YBBMEN(U7N'Z7F$V;'Q2.9TA7.T(((I( M!P*] 2IA4HY2 S$]RR1J1<@'',F:L,3[T.3\W$ DD;@"9!HMMXIXTKPMCH MFMY'L^"./#1/!2@C94[.^, +M@$E 3E-I=KR&W*)O(,;+^(@.7X6-YX-;2[8 M!#1ELBXGM[>R4::U?*/,+UW/GL _@W#H?/S_4$L! A0#% @ ]HQ46WHK M4-$Z$@ E:0 ! ( ! &1H&UL4$L! A0#% @ M]HQ46_K.I'2O"0 _5 !0 ( !*TL &1H&UL4$L! A0#% @ ]HQ46_ZO<#=<. COL" !8 M ( !#%4 &1H#DY,2YH=&U02P4& < !P#' ) 0 G(T end XML 18 dhr-20251021_htm.xml IDEA: XBRL DOCUMENT 0000313616 2025-10-21 2025-10-21 0000313616 us-gaap:CommonStockMember 2025-10-21 2025-10-21 0000313616 dhr:A0.2SeniorNotesDue2026Member 2025-10-21 2025-10-21 0000313616 dhr:A2.1SeniorNotesDue2026Member 2025-10-21 2025-10-21 0000313616 dhr:A1.2SeniorNotesDue2027Member 2025-10-21 2025-10-21 0000313616 dhr:A0.45SeniorNotesDue2028Member 2025-10-21 2025-10-21 0000313616 dhr:A2.5SeniorNotesDue2030Member 2025-10-21 2025-10-21 0000313616 dhr:A0.75SeniorNotesDue2031Member 2025-10-21 2025-10-21 0000313616 dhr:A1.35SeniorNotesDue2039Member 2025-10-21 2025-10-21 0000313616 dhr:A1.8SeniorNotesDue2049Member 2025-10-21 2025-10-21 false 0000313616 8-K 2025-10-21 DANAHER CORPORATION DE 001-08089 59-1995548 2200 Pennsylvania Avenue, N.W., 20037-1701 Suite 800W Washington, DC 202 828-0850 false false false false Common stock, $0.01 par value DHR NYSE 0.200% Senior Notes due 2026 DHR/26 NYSE 2.100% Senior Notes due 2026 DHR 26 NYSE 1.200% Senior Notes due 2027 DHR/27 NYSE 0.450% Senior Notes due 2028 DHR/28 NYSE 2.500% Senior Notes due 2030 DHR 30 NYSE 0.750% Senior Notes due 2031 DHR/31 NYSE 1.350% Senior Notes due 2039 DHR/39 NYSE 1.800% Senior Notes due 2049 DHR/49 NYSE false